Other specified/unspecified hearing loss

H8_HL_NAS

sensorineural hearing loss: Hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H91.8, H91.9 Hospital discharge: ICD-9 — 389[8-9] Hospital discharge: ICD-8 — 389 Cause of death: ICD-10 — H91.8, H91.9 Cause of death: ICD-9 — 389[8-9] Cause of death: ICD-8 — 389 2 out of 7 registries used, show all original rules.	4380
4. Check minimum number of events None	4380
5. Include endpoints None	4380
6. Filter based on genotype QC (FinnGen only)	3918

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	H8_HL_NAS
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H91[8-9]
HD_ICD_9	389[8-9]
HD_ICD_8	389
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H91[8-9]
COD_ICD_9	389[8-9]
COD_ICD_8	389
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specified/unspecified hearing loss based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30941	15915	14885
Only index persons	27863	14799	13064
Unadjusted period prevalence (%)
Whole population	0.44	0.46	0.42
Only index persons	0.52	0.54	0.50
Median age at first event (years)
Whole population	68.04	69.82	66.22
Only index persons	68.95	70.43	67.26

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3918	2024	1894
Unadjusted period prevalence (%)	0.79	0.72	0.87
Median age at first event (years)	67.30	64.32	70.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4060: Matched controls
40600

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H93.1

ICD-10 Finland

Tinnitus

9.9

323.0

388

429

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

38.8

307.7

640

195

DFF15

NOMESCO Finland

Speech audiometry

22.4

307.7

499

252

Z01.1

ICD-10 Finland

Examination of ears and hearing

14.5

307.7

1625

1790

R5120

NOMESCO Finland

Preparation of an aid

24.5

307.7

557

262

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

79.4

307.7

609

H91.9

ICD-10 Finland

Hearing loss, unspecified

427.0

307.7

3349

443

H02

ICPC

Hearing complaint

7.4

307.7

1336

2536

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

38.0

307.7

339

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

116.6

307.7

1959

322

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

116.1

307.7

311

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

27.3

307.7

894

415

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

4.7

307.7

969

2536

H91.1

ICD-10 Finland

Presbycusis

9.3

307.7

486

586

DFF00

NOMESCO Finland

Pure tone audiometry

23.1

307.7

1138

673

Z97.4

ICD-10 Finland

Presence of external hearing-aid

34.2

307.7

705

248

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

115.9

307.7

369

H91.8

ICD-10 Finland

Other specified hearing loss

72.5

307.7

514

DAX08

NOMESCO Finland

Fitting of hearing aid

36.6

307.7

553

174

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

231.8

307.7

240

N07CA01

ATC

betahistine; oral

5.9

282.4

556

1063

R5140

NOMESCO Finland

Monitoring the use of the aid

4.5

279.0

809

2147

UDC00

NOMESCO Finland

Ear microscopy

6.9

274.7

454

729

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

84.5

232.5

123

Z3229

NOMESCO Finland

Other healthcare associate professional

4.6

229.1

603

1472

H29

ICPC

Ear symptom/complaint other

3.8

226.5

809

2473

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

43.4

197.7

118

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

14.5

196.1

179

129

Z71.8

ICD-10 Finland

Other specified counselling

2.6

179.0

1753

9284

38990

ICD-8 Finland

Other deafness, Partialis uni-sive bilateralis

+∞

174.2

166

R4135

NOMESCO Finland

Rehabilitation for hearing problems

30.6

171.9

113

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

32.7

153.8

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

40.4

149.9

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

18.9

135.3

107

H81

ICPC

Excessive ear wax

2.6

133.2

972

4373

H81.0

ICD-10 Finland

Ménière disease

7.6

118.0

171

235

H80.9

ICD-10 Finland

Otosclerosis, unspecified

21.4

117.6

SPAT1043

SPAT

Audiometry

3.5

117.0

445

1387

RK520, ,

NOMESCO Finland

33.8

114.5

H61.2

ICD-10 Finland

Impacted cerumen

3.5

113.3

434

1358

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

112.3

1281

6950

DC1AD

NOMESCO Finland

Temporalbone CT

17.4

111.9

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

219.7

104.1

107

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.7

103.6

356

1036

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.3

102.0

409

1314

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

10.3

102.0

115

R1260

NOMESCO Finland

Evaluation of communicative skills

7.4

99.6

146

203

R42

ICD-10 Finland

Dizziness and giddiness

2.2

98.8

1152

6252

ZXA00

NOMESCO Finland

Right side

2.0

90.2

1304

7630

H13

ICPC

Plugged feeling ear

2.2

89.1

921

4738

R4110

NOMESCO Finland

Physiotherapy

2.0

87.8

1364

8173

ZXA05

NOMESCO Finland

Left side

2.0

85.9

1213

7014

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

14.5

85.3

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

35.8

84.4

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.5

84.3

212

490

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

29.3

78.0

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

9.1

76.8

105

SPAT1041

SPAT

Comprehensive hearing test

11.1

76.4

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

75.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

74.8

1312

8103

TDA90, ,

SPAT

3.0

74.6

364

1306

RK320, ,

NOMESCO Finland

10.2

71.8

Z01.7

ICD-10 Finland

Laboratory examination

2.1

71.1

802

4228

H92.0

ICD-10 Finland

Otalgia

3.4

69.9

262

803

H65.3

ICD-10 Finland

Chronic mucoid otitis media

6.2

67.1

116

192

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

6.1

66.1

116

195

RK110, ,

NOMESCO Finland

9.6

63.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

62.7

438

1881

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

5.7

61.0

115

207

H84

ICPC

Presbyacusis

3.9

60.7

185

493

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

7.9

59.5

106

ZXA10

NOMESCO Finland

Bilateral

2.0

58.9

834

4737

R39.1

ICD-10 Finland

Other difficulties with micturition

3.6

57.6

198

573

M79.6

ICD-10 Finland

Pain in limb

1.7

56.7

1741

12434

Z29.8

ICD-10 Finland

Other specified prophylactic measures

4.0

56.5

166

431

ZYC01

NOMESCO Finland

Remote contact by phone

2.8

53.9

295

1122

DFF59

NOMESCO Finland

Other assessment of balance

8.3

53.0

DDA00

NOMESCO Finland

Stapedotomy

14.3

52.8

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

21.9

52.5

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

7.7

52.2

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

52.2

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

51.8

1360

9256

H81.3

ICD-10 Finland

Other peripheral vertigo

3.8

51.1

159

430

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.6

50.8

326

1341

H71

ICD-10 Finland

Cholesteatoma of middle ear

8.2

50.4

Z2221

NOMESCO Finland

Medical doctor

1.7

50.2

1153

7550

R01AD09

ATC

mometasone; nasal

1.7

50.1

1621

11626

DFF16

NOMESCO Finland

Speech-in-noise audiometry

+∞

50.1

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.7

49.2

276

1062

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

4.0

48.9

143

370

RK120, ,

NOMESCO Finland

17.9

48.1

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

47.6

523

2699

H28

ICPC

Limited function/disability (H)

6.6

47.2

117

H83.3

ICD-10 Finland

Noise effects on inner ear

7.7

46.3

N02BE01

ATC

paracetamol; systemic, rectal

2.0

46.0

3549

31548

H66.9

ICD-10 Finland

Otitis media, unspecified

2.8

45.3

243

913

38920

ICD-8 Finland

Other deafness, Deafness, one ear

+∞

44.9

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

44.7

470

2382

R51.80

ICD-10 Finland

Headache

2.0

44.6

592

3262

M25.5

ICD-10 Finland

Pain in joint

1.7

44.5

1238

8484

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

2.1

44.3

462

2335

Z3226

NOMESCO Finland

Physiotherapist

1.8

44.1

804

4901

H65.2

ICD-10 Finland

Chronic serous otitis media

5.9

43.9

136

H01

ICPC

Ear pain/earache

2.1

43.8

443

2213

A28

ICPC

Limited function/disability NOS

1.7

43.5

918

5834

A98

ICPC

Health maint/preventive medicine

2.3

43.5

3752

34181

L17

ICPC

Foot/toe symptom/complaint

1.6

42.9

1244

8597

EB1AA, ,

SPAT

2.4

42.6

299

1281

38699, ,

ICD-8 Finland

11.7

42.1

D33.30

ICD-10 Finland

Acoustic neuroma

+∞

41.7

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

41.7

Z71.9

ICD-10 Finland

Counselling, unspecified

2.2

41.3

368

1747

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

41.2

1172

8045

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

41.0

1634

12154

A02BC02

ATC

pantoprazole; systemic

1.6

41.0

2718

22698

L28

ICPC

Limited function/disability (L)

1.7

40.8

901

5786

R06.0

ICD-10 Finland

Dyspnoea

1.6

40.6

1162

7984

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

39.4

759

4685

38998

ICD-8 Finland

Other deafness, Alia definita

+∞

38.6

H91

ICD-10 Finland

Other hearing loss

7.4

38.6

J01DB01

ATC

cefalexin; oral

1.7

38.0

3166

27629

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

37.9

1075

7348

H60.3

ICD-10 Finland

Other infective otitis externa

3.8

37.6

115

307

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

37.6

1364

9878

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

37.0

191

703

38999

ICD-8 Finland

Other deafness, Impairment of hearing, one or both ears

+∞

36.5

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

9.6

35.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

35.8

1695

12981

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

35.5

1093

7600

R5110, ,

SPAT

2.0

35.2

424

2250

ZYC01, ,

SPAT

2.0

35.1

418

2209

R05

ICD-10 Finland

Cough

1.7

35.0

838

5470

A97

ICPC

No disease

1.7

34.9

826

5374

R05

ICPC

Cough

1.6

34.9

950

6406

TDA90

NOMESCO Finland

Removal wax from ear

6.0

34.6

103

AA1AD

NOMESCO Finland

CT of head and brain

1.6

34.5

1217

8721

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.7

34.1

167

J01CA04

ATC

amoxicillin; systemic

1.6

33.4

3047

26619

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

33.4

424

2290

RK420, ,

NOMESCO Finland

329.8

32.9

R52.9

ICD-10 Finland

Pain, unspecified

2.0

32.9

416

2243

ZXH06, ,

SPAT

2.4

32.4

224

951

R74

ICPC

Upper respiratory infection acute

1.6

32.4

1023

7131

H04

ICPC

Ear discharge

2.9

32.3

152

532

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

6.7

31.8

R4130

NOMESCO Finland

Speech therapy

3.0

31.8

143

488

R83

ICPC

Respiratory infection other

1.6

31.7

793

5219

H02AB06

ATC

prednisolone; systemic

1.5

31.5

1829

14483

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

31.3

711

4565

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

31.1

849

5709

M54.5

ICD-10 Finland

Low back pain

1.5

30.8

1312

9743

38900

ICD-8 Finland

Other deafness, Deafness, both ears

+∞

30.2

3899X

ICD-9 Finland

Deafness, Unspecified deafness

+∞

30.2

H93.2

ICD-10 Finland

Other abnormal auditory perceptions

6.6

30.2

R03AC02

ATC

salbutamol; inhalant

1.5

30.0

1997

16180

WX110, ,

SPAT

2.3

29.9

236

1063

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.9

29.4

142

504

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

29.3

669

4294

U07

ICPC

Urine symptom/complaint other

1.9

29.2

379

2060

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

6.3

29.1

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

28.7

740

4895

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.6

28.6

169

667

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

28.4

441

2538

G44.2

ICD-10 Finland

Tension-type headache

1.8

28.2

475

2799

Z00.8

ICD-10 Finland

Other general examinations

2.0

28.2

327

1708

S18

ICPC

Laceration/cut

1.4

27.6

1808

14523

G04CA02

ATC

tamsulosin; oral

1.5

27.5

996

7115

RK530, ,

NOMESCO Finland

+∞

27.1

78159

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD

62.5

27.0

N17

ICPC

Vertigo/dizziness

1.7

26.7

529

3264

Z01.2

ICD-10 Finland

Dental examination

1.4

26.4

1562

12279

Z3231

NOMESCO Finland

Registered nurse

1.5

26.3

1078

7890

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

26.2

455

2705

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

26.1

659

4327

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

26.1

304

1590

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.4

25.9

EB1SA, ,

SPAT

2.4

25.6

188

821

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

25.4

320

1719

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

25.1

1589

12613

H02AB04

ATC

methylprednisolone; systemic

1.7

25.1

541

3410

R21

ICPC

Throat symptom/complaint

1.6

25.0

642

4228

J01FA10

ATC

azithromycin; systemic

1.4

25.0

1918

15747

H43

ICPC

Ear, Other diagnostic procedure

9.2

24.7

H60.8

ICD-10 Finland

Other otitis externa

2.8

24.7

124

450

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

24.7

1455

11394

R01AD08

ATC

fluticasone; nasal

1.5

24.5

933

6712

U02

ICPC

Urinary frequency/urgency

1.6

24.5

571

3671

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

24.5

924

6635

R01AD58

ATC

fluticasone, combinations; nasal

1.6

24.3

740

5072

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

24.3

1119

8362

AXX01, ,

SPAT

2.3

24.2

190

854

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

24.0

1390

10834

R4120

NOMESCO Finland

Occupational therapy

2.0

23.9

276

1438

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

23.7

1818

14880

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

5.2

23.6

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

23.6

628

4170

N06AX11

ATC

mirtazapine; oral

1.4

23.3

1234

9454

R53

ICD-10 Finland

Malaise and fatigue

1.5

23.2

962

7030

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.7

23.1

205

J01AA02

ATC

doxycycline; systemic

1.4

23.0

2915

25933

J01MA02

ATC

ciprofloxacin; systemic

1.4

23.0

1486

11786

A23

ICPC

Risk factor NOS

1.8

22.9

345

1963

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.0

22.8

102

348

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.4

22.5

154

651

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

22.5

266

1398

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

8.8

22.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

22.4

731

5078

ZY010, ,

SPAT

3.6

22.4

200

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

22.3

2455

21246

C07AB07

ATC

bisoprolol; oral

1.4

22.3

1987

16610

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

22.3

808

5741

R5130, ,

SPAT

6.5

22.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

22.1

702

4846

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

22.0

2534

22075

J01FA06

ATC

roxithromycin; oral

1.4

21.9

1424

11280

G47.3

ICD-10 Finland

Sleep apnoea

1.5

21.9

770

5432

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

21.9

298

1642

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

29.2

21.8

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

21.8

845

6082

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

21.7

897

6540

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

21.7

754

5307

R07.3

ICD-10 Finland

Other chest pain

1.7

21.6

405

2454

D19

ICPC

Teeth/gum symptom/complaint

1.5

21.5

1004

7491

N03AX16

ATC

[U] pregabalin

1.5

21.5

832

5984

H65.0

ICD-10 Finland

Acute serous otitis media

3.6

21.4

192

R06AX27

ATC

desloratadine; oral

1.5

21.4

896

6548

WX002

NOMESCO Finland

Sedation and analgesia

1.5

21.4

740

5202

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

21.3

542

3555

A11

ICPC

Chest pain NOS

1.8

21.1

347

2026

N30.0

ICD-10 Finland

Acute cystitis

1.5

21.0

642

4389

RK220, ,

NOMESCO Finland

7.7

20.8

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

20.7

290

1611

M01AH05

ATC

etoricoxib; oral

1.4

20.5

2132

18166

S29

ICPC

Skin symptom/complaint other

1.5

20.4

769

5493

GD1AA, ,

SPAT

1.6

20.3

498

3235

R02

ICPC

Shortness of breath/dyspnoea

1.6

20.2

530

3498

Z29.0

ICD-10 Finland

Isolation

6.8

19.9

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

19.8

499

3261

L12

ICPC

Hand/finger symptom/complaint

1.5

19.6

596

4066

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

3.0

19.6

296

N02AX02

ATC

tramadol; systemic, rectal

1.4

19.4

1609

13194

Z2446

NOMESCO Finland

Social worker

1.9

19.3

244

1312

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

7.5

19.1

RL210, ,

NOMESCO Finland

7.2

19.1

C10AA07

ATC

rosuvastatin; oral

1.4

18.9

1212

9525

H60

ICD-10 Finland

Otitis externa

2.1

18.9

174

835

M01AB05

ATC

diclofenac; systemic, rectal

1.3

18.7

2332

20303

M03BX02

ATC

tizanidine; oral

1.3

18.7

2076

17762

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

18.7

209

1078

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

18.6

1460

11850

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

100.5

18.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

18.5

1231

9727

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

18.4

297

1723

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

18.4

518

3471

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

18.4

291

1679

SFA10

NOMESCO Finland

One-surface restoration

1.3

18.2

1820

15305

R01AD12

ATC

fluticasone furoate; nasal

1.4

18.2

925

6977

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

18.0

460

3014

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

17.8

700

5030

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

17.8

177

875

J20

ICD-10 Finland

Acute bronchitis

1.7

17.8

351

2155

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.4

17.8

101

A02BC05

ATC

esomeprazole; systemic

1.4

17.7

1433

11657

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

4.5

17.7

R35

ICD-10 Finland

Polyuria

1.8

17.6

276

1588

RK290, ,

NOMESCO Finland

14.6

17.6

R06.5

ICD-10 Finland

Mouth breathing

1.8

17.5

292

1710

XG460

NOMESCO Finland

Short time oxymetry

3.0

17.4

267

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

17.4

126

548

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

17.3

365

2278

K02.1

ICD-10 Finland

Caries of dentine

1.3

17.3

1933

16474

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

17.3

581

4043

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

17.2

334

2041

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

17.1

606

4262

XF404

NOMESCO Finland

Ambulatory ECG

1.7

17.1

332

2029

L15

ICPC

Knee symptom/complaint

1.4

17.1

878

6628

A04

ICPC

Weakness/tiredness general

1.5

17.1

595

4172

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

3.3

17.1

192

UJF32

NOMESCO Finland

Coloscopy

1.4

17.0

952

7291

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

17.0

935

7139

R60.0

ICD-10 Finland

Localized oedema

1.5

17.0

502

3398

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

17.0

2185

18986

ZXD20

NOMESCO Finland

Day surgery

1.6

17.0

454

3005

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

4.5

16.8

Z45.3

ICD-10 Finland

Adjustment and management of implanted hearing device

+∞

16.7

R07.0

ICD-10 Finland

Pain in throat

1.9

16.6

216

1173

N01

ICPC

Headache

1.7

16.5

329

2023

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

16.5

221

1212

A85

ICPC

Adverse effect medical agent

3.5

16.5

162

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

16.4

428

2815

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

16.4

119

518

WX402

NOMESCO Finland

General anaesthesia

1.4

16.4

758

5610

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

16.3

1808

15345

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

16.3

598

4232

K30

ICD-10 Finland

Functional dyspepsia

1.6

16.2

383

2462

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

16.1

1302

10554

D11

ICPC

Diarrhoea

1.6

16.1

379

2433

C10AA05

ATC

atorvastatin; oral

1.3

16.0

1624

13605

XF402

NOMESCO Finland

ECG with work load test

1.6

15.9

392

2544

R55

ICD-10 Finland

Syncope and collapse

1.6

15.9

437

2909

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

15.8

3258

30185

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

15.7

1001

7814

L03

ICPC

Low back symptom/complaint

1.4

15.7

969

7525

M02AA07

ATC

piroxicam; topical

1.3

15.7

1301

10576

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

15.6

365

2337

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

15.6

704

5180

3897A

ICD-9 Finland

Deafness, Deaf mutism, not elsewhere classifiable[SURDITAS]

+∞

15.6

XKD00

NOMESCO Finland

Uroflowmetry

1.5

15.6

604

4320

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.2

15.5

125

569

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

15.5

2440

21674

A02BC03

ATC

lansoprazole; oral

1.4

15.4

1021

8016

H90

ICD-10 Finland

Conductive and sensorineural hearing loss

14.8

15.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

15.2

631

4569

D01

ICPC

Abdominal pain/cramps general

1.6

15.2

403

2659

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

15.2

357

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

15.1

861

6595

L08

ICPC

Shoulder symptom/complaint

1.4

15.1

791

5973

H26.4

ICD-10 Finland

After-cataract

1.6

15.0

419

2797

R5599

NOMESCO Finland

Other rehabilitation service

2.4

15.0

100

420

C10AA01

ATC

simvastatin; oral

1.3

14.9

1660

14038

D07AC01

ATC

betamethasone; topical

1.3

14.9

1274

10384

DCD00

NOMESCO Finland

Myringoplasty

5.4

14.9

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

14.9

468

3206

S02CA02

ATC

flumetasone and antiinfectives; otic

1.9

14.9

195

1061

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

6.8

14.8

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

14.7

675

4981

M79.1

ICD-10 Finland

Myalgia

1.5

14.6

468

3219

R13

ICD-10 Finland

Dysphagia

1.7

14.6

267

1605

SFA30

NOMESCO Finland

Three-surface restoration

1.3

14.6

1383

11435

Z26.8

ICD-10 Finland

Need for immunization against other specified single infectious diseases

3.6

14.5

132

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

6.6

14.5

S06.0

ICD-10 Finland

Concussion

1.6

14.4

362

2357

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

14.4

935

7307

M54.3

ICD-10 Finland

Sciatica

1.8

14.3

211

1191

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.8

14.3

227

1312

K85

ICPC

Elevated blood pressure

1.4

14.2

644

4736

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

14.2

158

814

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

14.2

672

4982

R12

ICD-10 Finland

Heartburn

1.7

14.0

272

1662

R03BA02

ATC

budesonide; inhalant

1.4

14.0

599

4361

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

3.2

13.9

175

R03DC03

ATC

montelukast; oral

1.5

13.9

514

3639

R51

ICD-10 Finland

Headache

2.0

13.8

160

836

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

13.8

264

1606

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

13.7

602

4400

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

13.7

355

2328

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

6.2

13.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.7

1359

11280

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

13.7

276

1703

R3110

NOMESCO Finland

Psychosocial training

4.2

13.7

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

13.6

175

947

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

13.6

228

1338

38910

ICD-8 Finland

Other deafness, Deafness, one ear and partial deafness in other

+∞

13.5

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

13.5

300

1896

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

34.1

13.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

13.4

881

6887

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

13.4

219

1275

GX1K5

NOMESCO Finland

Diffusion capacity

4.2

13.4

D12

ICPC

Constipation

2.0

13.4

149

768

R06AE07

ATC

cetirizine; oral

1.3

13.4

1433

12010

SDA03

NOMESCO Finland

Periodontal treatment

1.3

13.3

1258

10366

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

13.3

215

1249

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

13.2

992

7913

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.7

13.2

112

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

13.2

433

2993

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

13.1

885

6943

A02BC01

ATC

omeprazole; systemic

1.3

13.1

973

7743

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

13.1

125

609

R5430

NOMESCO Finland

Interpreter's services

12.2

13.1

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

13.0

231

S01BC05

ATC

ketorolac; ophthalmic

1.9

13.0

152

797

J01DA01

ATC

[U] cefalexin

1.3

12.9

2178

19299

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

12.9

247

1504

U71

ICPC

Cystitis/urinary infection other

1.7

12.8

240

1453

TQW40, ,

SPAT

1.6

12.8

341

2252

P01AB01

ATC

metronidazole; oral, rectal

1.3

12.8

1320

10995

OAB42, ,

SPAT

1.5

12.7

424

2940

UJF32, ,

SPAT

2.0

12.7

127

631

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

12.7

1057

8550

T16

ICD-10 Finland

Foreign body in ear

3.8

12.6

ZYC05, ,

SPAT

2.3

12.6

428

F29

ICPC

Eye symptom/complaint other

1.5

12.6

349

2325

H73.1

ICD-10 Finland

Chronic myringitis

32.1

12.6

WZC30

NOMESCO Finland

Teaching

1.4

12.5

588

4347

3898X

ICD-9 Finland

Deafness, Other specified forms of deafness

+∞

12.5

DFF05, ,

SPAT

3.2

12.5

156

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.4

12.4

131

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

12.4

396

2720

XG466

NOMESCO Finland

Sleep oxymetry

2.1

12.4

111

529

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

12.4

1280

10653

KMAK, ,

NOMESCO Finland

1.3

12.4

1595

13650

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

12.3

343

2286

J45.8

ICD-10 Finland

Mixed asthma

2.1

12.3

117

570

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

12.3

1229

10181

ZX120

NOMESCO Finland

Intravenous

1.5

12.2

349

2340

EBA00, ,

SPAT

2.2

12.2

453

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

12.2

1462

12391

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

12.2

267

1683

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

12.2

344

2301

PA6AD

NOMESCO Finland

CT of neck arteries

1.9

12.1

144

760

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

12.1

340

2273

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

12.1

677

5155

K80

ICPC

Cardiac arrhythmia NOS

1.6

12.0

302

1967

N30

ICD-10 Finland

Cystitis

1.6

12.0

264

1665

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

12.0

400

2770

R96

ICPC

Asthma

1.5

12.0

329

2186

H03

ICPC

Tinnitus, ringing/buzzing ear

2.6

11.9

248

A01

ICPC

Pain general/multiple sites

1.5

11.9

355

2402

ZY010

NOMESCO Finland

Hospital outpatient

1.9

11.9

149

800

H69.0

ICD-10 Finland

Patulous Eustachian tube

4.4

11.9

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

11.9

339

2273

Z50.5

ICD-10 Finland

Speech therapy

3.0

11.9

166

B01AC04

ATC

clopidogrel; oral

1.4

11.8

648

4913

M19.8

ICD-10 Finland

Other specified arthrosis

1.9

11.8

145

774

L57.0

ICD-10 Finland

Actinic keratosis

1.5

11.8

411

2873

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

11.8

213

1278

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

11.8

181

1037

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

11.7

326

2175

J45

ICD-10 Finland

Asthma

1.5

11.6

326

2176

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

11.6

445

3166

J01DA06

ATC

[U] cefuroxime

1.4

11.6

462

3311

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.5

11.6

287

M54

ICD-10 Finland

Dorsalgia

1.5

11.6

374

2573

L01

ICPC

Neck symptom/complaint

1.4

11.6

503

3665

S20.2

ICD-10 Finland

Contusion of thorax

1.8

11.6

187

1087

D06

ICPC

Abdominal pain localized other

1.6

11.5

277

1788

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

11.5

923

7413

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

11.4

245

1536

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

120.4

11.4

RK240, ,

NOMESCO Finland

120.4

11.4

SFA20

NOMESCO Finland

Two-surface restoration

1.3

11.4

1855

16265

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

11.4

958

7738

B01AF02

ATC

apixaban; oral

1.4

11.4

530

3909

H51

ICPC

Ear, I&d/flush/aspiration

2.8

11.4

203

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.4

11.3

119

M48.0

ICD-10 Finland

Spinal stenosis

1.4

11.3

456

3276

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

11.3

316

2108

A08

ICPC

Swelling

1.7

11.3

223

1369

Z2445

NOMESCO Finland

Psychologist

2.1

11.3

109

535

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

11.3

136

722

SAA01, ,

SPAT

3.4

11.2

115

R4190

NOMESCO Finland

Nutritional therapy

1.9

11.2

132

695

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.0

11.2

126

653

R03BA05

ATC

fluticasone; inhalant

1.4

11.2

581

4364

J01FA09

ATC

clarithromycin; systemic

1.3

11.2

960

7776

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

11.2

164

927

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

11.1

256

1633

ZXH09, ,

SPAT

2.4

11.1

299

XCK00

NOMESCO Finland

Perimetry

1.7

11.1

224

1383

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.6

11.1

240

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

11.1

1333

11268

B01AB05

ATC

enoxaparin; parenteral

1.3

11.1

1120

9267

ZXC10

NOMESCO Finland

Use of laser

2.4

11.1

306

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

11.1

331

2242

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

11.0

257

1644

N05CF01

ATC

zopiclone; oral

1.3

11.0

1170

9737

M54.2

ICD-10 Finland

Cervicalgia

1.6

11.0

244

1542

N05AB04

ATC

prochlorperazine; systemic, rectal

2.3

11.0

382

G04BD12

ATC

mirabegron; oral

1.4

11.0

434

3107

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

11.0

549

4098

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

11.0

585

4413

S04

ICPC

Lump/swelling localized

1.5

11.0

355

2444

S21

ICPC

Skin texture symptom/complaint

1.4

11.0

535

3977

DC1AI

NOMESCO Finland

Cone beam CT of ear

43.4

10.9

J02AC01

ATC

fluconazole; systemic

1.3

10.9

1192

9960

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

10.8

1763

15428

K59.0

ICD-10 Finland

Constipation

1.7

10.8

208

1268

R03AC03

ATC

terbutaline; inhalant

1.4

10.8

450

3251

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

10.8

246

1565

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

10.8

775

6116

A03

ICPC

Fever

1.4

10.8

485

3552

J01FF01

ATC

clindamycin; systemic

1.3

10.8

893

7190

D07AB08

ATC

desonide; topical

1.5

10.8

357

2468

ZXE00

NOMESCO Finland

One hour or less

1.3

10.7

1325

11225

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

10.7

702

5465

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

10.7

349

2405

IHA10, ,

SPAT

2.2

10.7

412

R2110

NOMESCO Finland

Giving the first information

1.7

10.7

205

1249

M02AA10

ATC

ketoprofen; topical

1.4

10.7

536

4001

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

2.3

10.7

336

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.1

10.7

472

S80.0

ICD-10 Finland

Contusion of knee

1.6

10.6

235

1486

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

10.6

153

861

4133

FHL

Stapedectomy sampling

8.0

10.6

R09.8

ICD-10 Finland

Other specified symptoms and signs involving the circulatory and respiratory systems

3.7

10.6

H01.0

ICD-10 Finland

Blepharitis

1.7

10.6

203

1238

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

10.5

198

1200

R00.2

ICD-10 Finland

Palpitations

1.6

10.5

236

1496

SAA04

NOMESCO Finland

Special examination of mouth

1.8

10.5

158

899

SPAT1336

SPAT

Request for examination

1.9

10.5

135

732

R4110, ,

SPAT

1.4

10.5

444

3217

XQ800

NOMESCO Finland

Prick test

1.7

10.5

198

1202

J05AB11

ATC

valaciclovir; oral

1.4

10.5

472

3459

M01AX05

ATC

glucosamine; oral

1.3

10.5

700

5466

N05CF02

ATC

zolpidem; oral

1.4

10.4

542

4070

38801

ICD-8 Finland

Deaf mutism, Congenita

+∞

10.4

QAE99, ,

SPAT

2.8

10.4

179

UJD10, ,

SPAT

2.1

10.4

450

R06AX22

ATC

ebastine; oral

1.4

10.4

503

3731

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

10.4

1024

8432

UJH02

NOMESCO Finland

Anoscopy

1.9

10.3

134

729

XA402

NOMESCO Finland

ENMG

2.2

10.3

399

A06AD11

ATC

lactulose; oral

1.4

10.3

586

4463

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

10.3

121

637

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

4.3

10.3

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

10.3

111

568

P20

ICPC

Memory disturbance

1.4

10.3

556

4202

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

10.2

154

877

N03AX12

ATC

[U] gabapentin; oral

1.4

10.2

517

3864

N06AX16

ATC

venlafaxine; oral

1.4

10.2

403

2884

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

10.2

320

2189

WX290, ,

SPAT

2.0

10.2

103

515

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

10.2

636

4916

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

10.2

328

2257

R50.9

ICD-10 Finland

Fever, unspecified

1.4

10.1

505

3764

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

10.1

644

4990

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

10.1

579

4414

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

10.1

232

1480

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

10.0

215

1349

J01EA01

ATC

trimethoprim; systemic

1.3

10.0

886

7190

R31

ICD-10 Finland

Unspecified haematuria

1.4

10.0

384

2734

Z00.0

ICD-10 Finland

General medical examination

1.3

10.0

637

4938

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

10.0

168

989

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

40.2

10.0

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

9.9

291

1964

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

9.9

274

1826

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

9.9

291

1965

G04CA01

ATC

alfuzosin; oral

1.4

9.8

433

3161

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

8.1

9.8

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

8.1

9.8

WZC30, ,

SPAT

1.5

9.8

283

1902

H70.1

ICD-10 Finland

Chronic mastoiditis

9.5

9.7

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

2.8

9.7

169

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

9.7

434

3177

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

9.7

691

5443

E0000UV, ,

ATC

1.2

9.7

1394

11990

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

9.7

371

2641

DCD10

NOMESCO Finland

Tympanoplasty

13.4

9.7

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.3

9.6

107

K96

ICPC

Haemorrhoids

2.1

9.5

459

R52.2

ICD-10 Finland

Other chronic pain

1.9

9.5

124

676

A27

ICPC

Fear of other disease NOS

1.7

9.5

179

1086

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

9.5

200

1249

Z92.2

ICD-10 Finland

Personal history of long-term (current) use of other medicaments

15.0

9.5

ZXC60

NOMESCO Finland

Application of heat

2.6

9.5

194

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.8

9.5

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

9.5

216

1376

A49

ICPC

General and Unspecified, Other preventive procedure

3.3

9.4

108

DEE00

NOMESCO Finland

Osseous fixation of hearing aid

100.3

9.4

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

+∞

9.4

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.0

9.4

469

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

9.3

325

2270

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.3

1252

10673

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

9.3

197

1232

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

9.3

188

1162

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

9.3

1331

11425

J01DC02

ATC

cefuroxime; systemic

1.7

9.3

159

940

C10AX09

ATC

ezetimibe; oral

1.3

9.3

575

4432

C08CA01

ATC

amlodipine; oral

1.2

9.3

1448

12546

S02

ICPC

Pruritus

1.9

9.3

117

631

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

9.3

170

1024

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

9.3

433

3191

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

9.3

1096

9208

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

9.2

391

2833

H57.1

ICD-10 Finland

Ocular pain

1.9

9.2

112

597

UKC02

NOMESCO Finland

Cystoscopy

1.3

9.2

589

4562

J01

ICD-10 Finland

Acute sinusitis

1.8

9.2

147

853

R053, ,

ICD-10 Finland

1.9

9.2

105

549

R30.0

ICD-10 Finland

Dysuria

1.8

9.2

135

765

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

9.2

185

1144

L60.0

ICD-10 Finland

Ingrowing nail

1.7

9.2

152

892

R03BC03

ATC

nedocromil; inhalant

1.6

9.1

205

1301

R04

ICPC

Breathing problem other

1.8

9.1

127

707

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

9.1

106

557

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.6

9.1

186

1153

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.7

9.1

173

1053

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

9.1

281

1916

GX1D5

NOMESCO Finland

Flow volume spirometry

5.0

9.1

N03AX09

ATC

lamotrigine; oral

1.8

9.1

120

658

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

9.1

428

3160

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

9.0

153

903

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

9.0

265

1789

L02

ICPC

Back symptom/complaint

1.5

9.0

301

2086

R01AD05

ATC

budesonide; nasal

1.6

9.0

224

1459

R29

ICPC

Respiratory symptom/complaint other

1.6

8.9

211

1356

P06

ICPC

Sleep disturbance

1.4

8.9

364

2619

R11

ICD-10 Finland

Nausea and vomiting

1.5

8.9

294

2031

ZA1.0

ICD-10 Finland

Shoulder region

2.0

8.9

430

Y94.8

ICD-10 Finland

Other leisure activity accident

2.0

8.9

471

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.4

8.9

QBE99, ,

SPAT

3.0

8.9

128

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

8.9

604

4723

N02BF01

ATC

gabapentin; oral

1.5

8.8

315

2211

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.8

2240

20379

H31

ICPC

Ear, Medical examin/health eval partial

8.6

8.8

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

8.8

520

3982

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

8.8

233

1539

JFA15, ,

SPAT

3.2

8.8

108

F73

ICPC

Eye infection/inflammation other

2.2

8.8

301

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

8.7

149

881

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.7

8.7

147

866

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

8.7

239

1589

WZA30, ,

SPAT

2.9

8.7

135

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

8.7

128

726

H83.1

ICD-10 Finland

Labyrinthine fistula

50.1

8.7

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

2.1

8.7

374

L04

ICPC

Chest symptom/complaint

1.6

8.6

206

1327

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

8.6

136

787

K58

ICD-10 Finland

Irritable bowel syndrome

2.2

8.6

342

H69.9

ICD-10 Finland

Eustachian tube disorder, unspecified

4.4

8.6

C01DA14

ATC

isosorbide mononitrate; oral

1.3

8.6

627

4949

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

8.6

1458

12724

WZC00, ,

SPAT

1.4

8.6

451

3390

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

8.6

194

1235

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

8.6

495

3776

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.5

8.5

272

1867

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

8.5

230

1524

W19

ICD-10 Finland

Unspecified fall

1.4

8.5

334

2387

M01AC06

ATC

meloxicam; systemic, rectal

1.2

8.5

1180

10075

H02.3

ICD-10 Finland

Blepharochalasis

1.6

8.5

213

1389

NG1EA, ,

SPAT

2.8

8.5

148

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

8.5

344

2474

L13

ICPC

Hip symptom/complaint

1.3

8.4

660

5257

50499

ICD-8 Finland

Deflected nasal septum

2.3

8.4

274

H25

ICD-10 Finland

Senile cataract

2.6

8.4

177

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.2

8.4

300

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

8.4

419

3123

WZB00, ,

SPAT

1.5

8.4

246

1661

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

8.3

290

2026

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

8.3

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

8.3

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

8.3

127

728

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

8.3

183

1157

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

8.3

681

5459

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

8.3

345

2492

Z97.8

ICD-10 Finland

Presence of other specified devices

8.5

8.3

R31

NOMESCO Finland

Adaptation training

10.7

8.3

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

8.3

308

2180

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

8.3

104

562

H60.1

ICD-10 Finland

Cellulitis of external ear

2.8

8.3

139

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

8.2

150

905

M54.8

ICD-10 Finland

Other dorsalgia

1.7

8.2

140

829

R01AD01

ATC

beclometasone; nasal

1.4

8.2

450

3405

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

8.2

444

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

6.5

8.2

R19.4

ICD-10 Finland

Change in bowel habit

1.9

8.1

529

U01

ICPC

Dysuria/painful urination

1.5

8.1

242

1638

R4160, ,

SPAT

4.4

8.1

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

8.1

639

5092

A02BA02

ATC

ranitidine; systemic

1.3

8.1

657

5255

DFF00, ,

SPAT

2.5

8.1

198

R03BA01

ATC

beclometasone; inhalant

1.4

8.1

444

3357

F01

ICPC

Eye pain

2.0

8.1

446

XA410

NOMESCO Finland

BAEP

33.4

8.1

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

17.2

8.1

WYA30, ,

SPAT

3.2

8.1

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

8.0

153

933

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

2.0

8.0

420

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

22.1

8.0

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

8.0

212

1400

J05AB01

ATC

aciclovir; systemic

1.3

8.0

689

5559

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

8.0

510

3950

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

7.9

354

2589

SPAT1044

SPAT

Tympanometry

2.3

7.9

250

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

7.9

127

741

N05BA04

ATC

oxazepam; oral

1.3

7.8

879

7319

H53.8

ICD-10 Finland

Other visual disturbances

2.4

7.8

202

P29

ICPC

Psychological sympt/compl other

1.6

7.8

182

1168

G51.0

ICD-10 Finland

Bell palsy

2.0

7.8

418

N27

ICPC

Fear of neurological disease other

2.1

7.8

330

N06AB04

ATC

citalopram; systemic

1.3

7.8

668

5386

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

7.7

179

1146

C05AA08

ATC

fluocortolone; rectal, topical

1.4

7.7

421

3180

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

7.7

145

881

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

7.7

174

1107

H61.8

ICD-10 Finland

Other specified disorders of external ear

2.9

7.7

122

K02.2

ICD-10 Finland

Caries of cementum

1.6

7.7

157

974

R06AX13

ATC

loratadine; oral

1.4

7.7

398

2981

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

7.7

482

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

7.7

820

6785

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

7.6

129

762

GX2D5

NOMESCO Finland

Sleep oximetry

3.3

7.6

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

7.6

334

2434

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

7.6

680

5505

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

7.6

126

740

P01

ICPC

Feeling anxious/nervous/tense

1.4

7.6

281

1986

U13

ICPC

Bladder symptom/complaint other

1.8

7.6

106

592

P03

ICPC

Feeling depressed

1.5

7.6

240

1646

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

7.6

431

3278

N06AX21

ATC

duloxetine; oral

1.4

7.6

346

2540

L11

ICPC

Wrist symptom/complaint

1.5

7.6

268

1879

-44

ICPC

Preventive immunization/medic

0.6

7.6

111

1883

DDB00

NOMESCO Finland

Stapedectomy

11.9

7.6

M79.7

ICD-10 Finland

Fibromyalgia

1.9

7.5

500

J01MA14

ATC

moxifloxacin; systemic

1.4

7.5

293

2091

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.3

7.5

224

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

1.9

7.5

486

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

7.5

105

587

L29.9

ICD-10 Finland

Pruritus, unspecified

1.9

7.5

494

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.1

7.4

309

N30.8

ICD-10 Finland

Other cystitis

2.6

7.4

153

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

7.4

514

4023

78139

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Symptoma auditus aliud sive NUD

80.2

7.4

H71

ICPC

Acute otitis media/myringitis

2.8

7.4

125

D10

ICPC

Vomiting

1.7

7.4

140

853

S01.0

ICD-10 Finland

Open wound of scalp

1.4

7.4

272

1923

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

7.3

163

1035

G04CB01

ATC

finasteride; oral

1.4

7.3

403

3050

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

7.3

118

689

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

7.3

352

M01AX17

ATC

nimesulide; oral

1.3

7.3

803

6667

R5140, ,

SPAT

2.4

7.3

209

N03AE01

ATC

clonazepam; systemic

1.6

7.3

174

1124

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

7.3

364

2714

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

7.3

1154

9964

L95

ICPC

Osteoporosis

1.7

7.3

140

858

XG405, ,

SPAT

3.2

7.2

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.9

7.2

464

K05.38

ICD-10 Finland

Other chronic periodontitis

1.8

7.2

100

558

38790

ICD-8 Finland

Other disease of ear and mastoid process, Degeneratio nervi acustici

15.8

7.2

N05AH04

ATC

quetiapine; oral

1.3

7.2

519

4084

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

7.2

374

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.2

990

8422

R75

ICPC

Sinusitis acute/chronic

1.7

7.2

129

776

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

7.2

232

1599

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

7.2

190

1256

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

4.5

7.2

H02AB07

ATC

prednisone; oral

1.3

7.2

448

3456

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

7.2

1265

11034

R1430, ,

SPAT

2.3

7.2

223

H80

ICD-10 Finland

Otosclerosis

30.1

7.1

EB1CA, ,

SPAT

2.9

7.1

106

IAA01, ,

SPAT

3.4

7.1

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.0

7.1

390

IHZ07, ,

SPAT

3.3

7.1

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.1

842

7047

A92

ICPC

Allergy/allergic reaction NOS

1.9

7.1

418

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

7.1

185

1220

J46

ICD-10 Finland

Status asthmaticus

1.8

7.0

519

DGW00

NOMESCO Finland

Dilatation of eustachian tube

8.8

7.0

H92.2

ICD-10 Finland

Otorrhagia

10.0

7.0

S22.3

ICD-10 Finland

Fracture of rib

1.5

7.0

233

1615

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

7.0

204

1378

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

7.0

142

883

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.6

7.0

165

1064

4141

FHL

Myringoplasty (also for reasons other than inflammation)

4.4

7.0

N04BC05

ATC

pramipexole; oral

1.5

7.0

246

1726

T91

ICPC

Vitamin/nutritional deficiency

2.8

6.9

124

WX140

NOMESCO Finland

Parabulbar anesthesy

1.6

6.9

168

1089

N06AB10

ATC

escitalopram; oral

1.3

6.9

562

4493

H69.8

ICD-10 Finland

Other specified disorders of Eustachian tube

4.0

6.9

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.6

6.9

142

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

6.8

286

2069

F05.9

ICD-10 Finland

Delirium, unspecified

1.9

6.8

459

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.7

6.8

128

779

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.5

6.8

172

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

6.8

698

5741

S22

ICPC

Nail symptom/complaint

1.5

6.8

219

1508

M81.5

ICD-10 Finland

Idiopathic osteoporosis

2.7

6.8

131

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.7

6.8

131

D06BB03

ATC

aciclovir; topical

1.6

6.8

134

826

R49.03

ICD-10 Finland

Atrophic dysphonia

2.3

6.8

203

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.9

6.8

467

H74.1

ICD-10 Finland

Adhesive middle ear disease

6.7

6.8

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

6.8

518

Z23.5

ICD-10 Finland

Need for immunization against tetanus alone

2.6

6.8

149

N05AX08

ATC

risperidone; systemic

1.4

6.8

300

2193

W42

ICD-10 Finland

Exposure to noise

40.1

6.8

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

6.7

183

1217

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.7

6.7

117

698

R07.1

ICD-10 Finland

Chest pain on breathing

2.3

6.7

223

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

6.7

193

1299

N06AG02

ATC

moclobemide; oral

1.7

6.7

127

775

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.7

1134

9837

M35.7

ICD-10 Finland

Hypermobility syndrome

2.6

6.7

138

SPAT1342

SPAT

Referral to specialised care

2.4

6.7

186

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

6.7

189

1268

EMB30

NOMESCO Finland

Adenotomy

2.5

6.7

150

F05

ICPC

Visual disturbance other

1.7

6.7

104

602

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

6.7

240

1690

A46

ICD-10 Finland

Erysipelas

1.3

6.6

516

4101

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.0

6.6

351

ZXD35

NOMESCO Finland

Usual procedure

1.7

6.6

110

649

N64.4

ICD-10 Finland

Mastodynia

1.9

6.6

436

RS221, ,

NOMESCO Finland

2.3

6.6

206

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

6.6

147

935

M75.8

ICD-10 Finland

Other shoulder lesions

1.7

6.6

111

657

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

6.6

122

741

SPAT1325

SPAT

Vaccination

1.2

6.6

1102

9550

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.8

6.6

553

QXB99, ,

SPAT

1.8

6.6

509

K92.1

ICD-10 Finland

Melaena

1.5

6.6

193

1306

S12

ICPC

Insect bite/sting

1.4

6.5

280

2037

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.8

6.5

570

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.8

6.5

453

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.5

782

6552

3853A

ICD-9 Finland

Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid

6.2

6.5

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.7

6.4

120

730

J01DA08

ATC

[U] cefaclor

1.4

6.4

265

1913

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.8

6.4

542

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

6.4

168

1109

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

6.4

209

1444

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

6.4

698

5781

H92.1

ICD-10 Finland

Otorrhoea

7.4

6.4

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

14.3

6.4

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

6.4

291

2137

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.8

6.4

470

4222

FHL

Endonasal etmoidectomy

3.0

6.4

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

3.7

6.4

H70

ICPC

Otitis externa

2.0

6.3

302

G50.1

ICD-10 Finland

Atypical facial pain

2.2

6.3

236

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.9

6.3

393

L10

ICPC

Elbow symptom/complaint

1.6

6.3

146

938

RS220, ,

NOMESCO Finland

2.4

6.3

179

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

2.1

6.3

256

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

6.3

303

R15

ICD-10 Finland

Faecal incontinence

1.8

6.3

531

DCA30

NOMESCO Finland

Exploration of middle ear

18.0

6.3

DFF20

NOMESCO Finland

Audiometry for children

18.0

6.3

C01CA24

ATC

epinephrine; parenteral

1.5

6.3

157

1027

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

6.3

220

1543

N05CD07

ATC

temazepam; oral

1.3

6.3

421

3282

H91.0

ICD-10 Finland

Ototoxic hearing loss

+∞

6.2

3890A

ICD-9 Finland

Deafness, Conductive deafness

+∞

6.2

N06AB03

ATC

fluoxetine; oral

1.3

6.2

358

2727

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.8

6.2

1034

11858

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

6.2

577

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

6.2

503

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.7

6.2

102

600

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

6.2

409

3179

CK2S4, ,

SPAT

2.1

6.2

271

J33.8

ICD-10 Finland

Other polyp of sinus

2.1

6.2

271

J30.3

ICD-10 Finland

Other allergic rhinitis

1.8

6.2

504

D07AC13

ATC

mometasone; topical

1.2

6.2

910

7779

R52.0

ICD-10 Finland

Acute pain

1.7

6.2

571

M01AE02

ATC

naproxen; oral, rectal

1.2

6.2

1801

16374

183

Kela drug reimbursment

Lamotrigin and topiramate

3.1

6.2

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.3

6.1

200

D62

ICPC

Digestive, Administrative procedure

3.2

6.1

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

6.1

178

1202

L85.3

ICD-10 Finland

Xerosis cutis

2.4

6.1

169

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.5

6.1

205

1425

RK510, ,

NOMESCO Finland

7.7

6.1

SPAT1104

SPAT

Monitoring of emergency patient

0.6

6.1

1421

F99

ICPC

Eye/adnexa disease other

2.7

6.1

110

H53.2

ICD-10 Finland

Diplopia

1.7

6.1

101

596

I84

ICD-10 Finland

Hemorrhoids

1.8

6.1

470

H72.1

ICD-10 Finland

Attic perforation of tympanic membrane

12.5

6.1

A03FA02

ATC

cisapride; oral, rectal

1.4

6.1

239

1713

4147

FHL

Radical surgery, cavity filling and middle ear and / or eardrum plastic

8.6

6.0

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.9

6.0

371

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

6.0

221

1564

R49.01

ICD-10 Finland

Functional dysphonia

1.8

6.0

494

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

6.0

283

2091

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1228

6268

2.38

127.07

3.7

3.2

3.43

2.33

e6/l

2.18

652

3076

(40758558) Short blood count panel - Blood

1678

10773

1.95

88.50

7.8

6.5

—

(3018095) Leukocytes [#/volume] in Urine

1992

13735

1.88

82.77

5.8

4.2

110.71

107.22

e6/l

0.04

1383

9797

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3275

26721

2.17

81.38

28.3

22.3

13.79

0.05

3259

26343

(3002582) Erythrocytes [#/volume] in Urine

1798

12322

1.82

73.21

4.3

3.5

47.02

77.25

e6/l

1.23

1331

9426

(3000034) Microalbumin [Mass/volume] in Urine

148

288

5.30

72.16

3.2

2.9

59.95

41.52

mg/l

0.44

112

213

(4034850) Laboratory test

291

975

3.14

67.06

8.3

10.7

—

(3033658) Prothrombin time (PT) actual/Normal

1441

9483

1.81

65.07

4.2

4.3

88.05

86.96

0.92

1414

9288

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2215

16655

1.73

61.37

7.7

6.9

1.21

mmol/l

0.25

2126

15408

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1093

6772

1.84

59.10

3.4

3.1

0.89

1.12

e6/l

1.46

523

3601

(3019550) Sodium [Moles/volume] in Serum or Plasma

3737

33390

2.50

56.08

25.7

21.6

139.69

139.60

mmol/l

1.17

3713

32714

(3023103) Potassium [Moles/volume] in Serum or Plasma

3741

33443

2.51

56.05

26.0

21.8

3.97

3.98

mmol/l

1.92

3713

32709

(3030467) Casts [#/volume] in Urine by Automated count

1536

10682

1.70

54.71

3.9

3.4

0.41

0.48

e6/l

0.26

1049

7867

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2139

16232

1.67

54.60

2.5

2.2

95.66

94.13

pmol/l

0.89

1195

8517

(3014051) Protein [Presence] in Urine by Test strip

1404

9552

1.72

54.06

3.1

0.00

0.06

2.67

274

(3022689) Creatine [Moles/volume] in Urine

7.92

54.04

1.4

1.3

7.74

7.40

mmol/l

0.20

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3639

32282

2.23

53.28

22.0

18.0

25.19

26.40

mg/l

1.46

3154

27091

(3021589) Normoblasts [#/volume] in Blood

2038

15421

1.65

51.39

12.2

11.9

0.00

e9/l

1.16

1581

12433

(3021601) Nitrite [Presence] in Urine by Test strip

2292

17868

1.65

51.28

4.2

4.1

0.00

estimate

1.08

366

3804

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3138

26681

1.78

49.55

27.8

23.3

331.11

331.50

g/l

1.58

3128

26494

(3009261) Glucose [Presence] in Urine by Test strip

2317

18218

1.63

49.17

4.3

4.1

0.00

0.09

estimate

0.58

355

3660

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3778

34304

2.46

47.89

28.0

23.6

81.96

80.07

umol/l

1.91

3761

33824

(3031040) Bacteria [#/volume] in Urine by Automated count

2769

22849

1.67

47.75

5.7

5.0

823.04

2092.43

e6/l

0.74

366

(3035350) Ketones [Presence] in Urine by Test strip

2294

18082

1.62

47.41

4.2

4.1

9.99

4.87

estimate

0.41

385

3928

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3738

33817

2.33

47.26

13.9

12.7

25.41

25.59

u/l

0.23

3683

32771

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2042

15688

1.61

46.63

2.6

2.4

78.71

78.32

nmol/l

0.26

1929

14069

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3111

26557

1.73

46.35

8.8

8.5

79.06

81.97

u/l

3.10

3013

25171

(3014111) Lactate [Moles/volume] in Serum or Plasma

655

3695

1.92

46.16

6.9

7.6

1.33

1.36

mmol/l

0.21

631

3614

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1118

7433

1.70

45.22

4.3

4.1

405.75

511.61

ng/l

0.27

901

6165

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3412

29999

1.86

44.96

6.0

5.4

1.92

1.98

mu/l

1.92

3267

27560

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3491

30995

1.90

43.49

22.4

18.0

76.67

77.18

ml/min/173m2

0.77

3269

28869

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3800

34823

2.42

43.08

31.9

26.9

91.53

91.48

0.25

3783

34371

(3035941) MCH [Entitic mass]

3800

34824

2.42

43.06

31.9

26.9

30.42

30.38

0.89

3784

34371

(3026361) Erythrocytes [#/volume] in Blood

3800

34826

2.42

43.02

32.0

27.0

4.41

4.42

e12/l

0.93

3711

33881

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3800

34827

2.42

42.99

32.7

27.5

39.87

39.86

0.03

3782

34360

(3010813) Leukocytes [#/volume] in Blood

3800

34834

2.42

42.85

32.0

27.0

6.83

6.85

e9/l

0.11

3710

33880

(3000963) Hemoglobin [Mass/volume] in Blood

3800

34835

2.42

42.83

32.2

27.2

132.95

133.34

g/l

0.88

3782

34398

(3007461) Platelets [#/volume] in Blood

3798

34819

2.41

42.62

32.0

27.0

241.82

247.89

e9/l

7.28

3720

34018

(3030981) Hyaline casts [#/volume] in Urine by Automated count

558

3093

1.93

41.12

3.2

2.5

0.38

0.55

e6/l

1.37

530

2983

(3018418) pH of Serum or Plasma

1548

11427

1.57

39.87

4.7

4.2

7.40

0.03

921

8253

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2299

18589

1.55

38.95

7.8

7.6

1.21

mmol/l

1.03

2149

16052

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

617

3612

1.84

38.17

2.7

2.5

33.75

41.27

u/l

2.36

522

3041

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3475

31142

1.80

37.41

5.6

5.4

6.00

6.02

mmol/l

0.48

3334

28374

(3013826) Glucose [Moles/volume] in Serum or Plasma

2520

20910

1.54

37.00

5.8

5.3

6.72

6.79

mmol/l

1.01

2423

19884

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2903

24873

1.59

36.85

4.9

4.4

13.08

13.57

mm/h

1.02

2793

23138

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3543

31974

1.85

36.76

6.5

6.0

2.58

2.63

mmol/l

2.84

3416

29519

(3013650) Neutrophils [#/volume] in Blood by Automated count

2418

19913

1.53

36.53

10.2

9.7

4.12

4.22

e9/l

1.27

2011

17044

(3019150) Specific gravity of Urine by Refractometry

1126

7849

1.60

36.32

4.1

4.3

1.02

1.21

kg/l

0.50

707

5339

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2302

18837

1.51

35.24

6.3

6.8

12.41

12.34

umol/l

0.05

2223

18010

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2917

25121

1.57

35.22

4.7

4.4

14.89

14.91

pmol/l

0.14

2760

22907

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1971

15623

1.51

35.12

3.5

3.1

138.93

137.76

ug/l

0.05

1885

14512

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3408

30529

1.72

34.69

7.1

6.7

39.71

39.84

mmol/mol

0.41

3309

28406

(3024561) Albumin [Mass/volume] in Serum or Plasma

2072

16638

1.50

34.39

5.3

5.2

35.63

34.99

g/l

5.99

1972

15542

(3021960) Folate [Moles/volume] in Serum or Plasma

1443

10789

1.52

33.50

1.8

1.7

21.60

20.01

nmol/l

3.54

1321

9160

(3037467) Urinalysis macro (dipstick) panel - Urine

2735

23326

1.53

33.50

5.1

4.8

1.61

2.04

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1546

11751

1.51

33.08

3.4

3.3

1559.01

1759.31

ng/l

1.12

1401

10292

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1103

7800

1.57

32.86

3.1

2.46

mmol/l

1.09

999

6960

(3001604) Monocytes [#/volume] in Blood

2156

17593

1.48

32.11

6.9

6.3

0.63

0.60

e9/l

0.61

1777

14827

(3006315) Basophils [#/volume] in Blood

2161

17646

1.48

32.05

6.9

6.3

0.04

e9/l

0.06

1767

14886

(3019198) Lymphocytes [#/volume] in Blood

2187

17974

1.47

30.89

7.0

6.3

1.94

1.89

e9/l

0.25

1828

15533

(3013115) Eosinophils [#/volume] in Blood

2205

18156

1.47

30.81

7.4

6.5

0.19

0.20

e9/l

0.32

1837

15572

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3452

31345

1.68

29.55

5.3

5.2

4.45

4.55

mmol/l

7.29

3326

29032

(3015736) pH of Urine

1807

14396

1.46

29.46

3.8

3.6

6.11

6.25

4.71

731

7875

(3018010) Neutrophils/Leukocytes in Blood

2004

16328

1.45

28.76

6.9

6.4

57.73

57.94

0.34

1931

15538

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

659

4252

1.66

28.18

2.8

8.51

9.23

umol/l

0.27

581

3727

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

134

476

2.88

27.75

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

848

5865

1.56

27.06

2.2

2.1

29.81

0.01

841

5711

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2160

17966

1.43

27.00

2.9

2.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3414

31107

1.61

26.53

5.0

5.1

1.43

1.46

mmol/l

4.04

3276

28610

(3026782) Osmolality of Urine

1017

7353

1.51

26.37

4.0

3.0

539.61

529.86

mosm/kgh2o

0.83

903

6407

(3019069) Monocytes/Leukocytes in Blood

1991

16374

1.42

26.16

7.2

6.6

9.11

9.01

0.68

1907

15270

(3002030) Lymphocytes/Leukocytes in Blood

2018

16665

1.42

25.74

7.1

6.5

26.97

26.83

0.22

1941

15726

(3006504) Eosinophils/Leukocytes in Blood

1985

16345

1.42

25.74

7.1

6.5

2.80

2.84

0.34

1898

15246

(3022096) Basophils/Leukocytes in Blood

1981

16341

1.41

25.23

7.2

6.6

0.67

0.66

0.26

1895

15232

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1299

9938

1.45

25.09

2.4

2.66

2.86

mg/l

2.00

1136

8604

(3015377) Calcium [Moles/volume] in Serum or Plasma

1603

12844

1.41

23.58

3.6

2.36

2.35

mmol/l

0.78

1491

11619

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

353

2020

1.82

22.98

1.8

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1206

9232

1.44

22.73

2.9

346.72

350.12

umol/l

0.51

1097

8062

(3032080) INR in Blood by Coagulation assay

2048

17215

1.38

22.16

16.3

17.0

1.28

1.31

inr

1.14

1656

14382

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1432

11374

1.40

21.65

3.3

30.16

37.21

u/l

3.34

1367

10706

(3042936) Bacteria identified in Isolate by Culture

740

5192

1.52

21.57

2.2

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

607

4078

1.57

21.52

2.0

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

210

3986

0.50

21.29

5.5

5.1

31.70

33.02

1.06

151

2553

(3026008) Bacteria identified in Urine by Culture

1453

11596

1.39

21.25

3.6

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

875

6372

1.48

21.22

1.6

1.5

2.33

2.54

g/l

2.23

498

3785

(3002173) Hemoglobin [Mass/volume] in Arterial blood

578

3864

1.58

20.90

8.0

8.4

120.80

119.98

g/l

0.47

572

3767

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

791

5672

1.49

20.66

2.8

2.7

22.56

21.69

1.06

759

5290

(3022948) Iron [Moles/volume] in Serum or Plasma

889

6536

1.46

20.42

2.8

2.7

13.02

12.30

umol/l

2.27

854

6085

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

244

1289

1.95

20.32

2.2

0.03

g/l

0.11

232

1158

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

411

2547

1.68

20.15

8.3

9.3

24.54

24.23

mmol/l

1.24

399

2488

(3016502) Oxygen saturation in Arterial blood

615

4211

1.54

19.93

7.6

7.9

95.39

95.32

0.08

601

4065

(3004789) Transferrin [Mass/volume] in Serum or Plasma

838

6121

1.47

19.84

2.8

2.6

2.27

g/l

0.10

802

5665

(3044640) Blood type and Crossmatch panel - Blood

1452

11696

1.38

19.66

2.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1632

13470

1.35

18.64

2.0

1.9

1.36

1.34

mmol/l

0.61

1497

11298

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3240

29759

1.44

18.56

4.2

4.3

1.31

1.28

mmol/l

1.08

3056

27062

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

664

4693

1.50

18.42

2.1

1.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

670

4745

1.49

18.40

7.2

7.6

12.45

12.17

kpa

0.67

648

4540

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

670

4746

1.49

18.38

7.2

7.6

5.10

kpa

0.01

649

4537

(3019977) pH of Arterial blood

668

4730

1.49

18.36

7.3

7.6

7.42

0.94

283

2537

(3003396) Base excess in Arterial blood by calculation

666

4713

1.49

18.35

7.3

7.5

0.89

0.92

mmol/l

0.07

580

3858

(3000991) Gas panel - Venous blood

531

3591

1.55

18.09

9.3

8.7

—

(3000494) Fungus identified in Specimen by Culture

581

4020

1.52

17.80

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

571

3943

1.52

17.65

2.0

2.3

122.91

145.82

ug/g

0.95

479

3121

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

947

7222

1.41

17.40

1.3

1.42

1.70

u/ml

0.34

239

1873

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

645

4581

1.49

17.38

1.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

414

2671

1.61

17.23

9.4

1.25

1.28

0.36

409

2652

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

689

4978

1.46

16.99

2.1

1.8

—

(3019225) pH of Specimen

187

3410

0.53

16.49

3.8

4.7

7.36

0.07

130

2484

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

776

5771

1.43

16.32

1.3

26.48

34.47

iu/ml

1.37

209

1768

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

237

4007

0.57

16.07

6.7

7.3

—

(3000850) Epithelial cells [#/volume] in Urine

1083

8557

1.36

15.79

3.0

2.8

4.51

5.54

e6/l

2.65

988

7761

(3013139) Helicobacter pylori Ag [Presence] in Stool

356

2262

1.63

15.74

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

1706

1.71

15.56

2.5

2.3

3.69

3.75

g/l

0.17

271

1556

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

1707

1.71

15.53

2.5

2.3

4.16

4.18

g/l

0.16

271

1557

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

1708

1.71

15.50

2.5

2.3

7.19

7.50

g/l

2.74

271

1556

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1614

13575

1.31

15.20

4.8

4.0

38.23

92.65

ng/l

1.04

1194

10068

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

340

2155

1.63

15.17

2.5

2.4

23.08

20.90

au/ml

0.19

188

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

1611

1.72

15.16

2.5

2.3

2.81

2.98

g/l

2.19

257

1460

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

256

1513

1.74

14.87

2.3

0.71

0.90

g/l

0.48

237

1293

(40768804) Tissue Pathology biopsy report

1610

13601

1.30

14.46

2.3

2.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

208

1171

1.82

14.26

2.0

2.3

0.00

g/l

-0.00

199

1097

(40768797) Stomach Pathology biopsy report

640

4701

1.43

14.24

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1369

11360

1.31

13.88

2.4

2.2

183.43

210.20

u/l

0.67

1327

10704

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

385

2580

1.54

13.53

2.0

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

308

1968

1.61

13.29

1.4

1.3

46.19

56.86

au/ml

0.44

140

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1336

11107

1.30

13.20

2.9

2.7

59.73

67.38

u/l

0.51

1273

10282

(3023368) Bacteria identified in Blood by Culture

1311

10875

1.30

13.16

5.0

4.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1373

11483

1.30

12.89

5.9

5.7

3.13

3.34

ug/l

0.13

1286

10314

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

212

1249

1.74

12.48

2.0

2.2

0.00

g/l

-0.00

199

1099

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

936

7493

1.32

11.96

1.9

1.8

1.44

1.42

mg/l

0.06

743

5870

(3003327) Ova and parasites identified in Stool by Light microscopy

185

1064

1.77

11.85

1.6

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

404

2815

1.48

11.77

1.5

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1494

1.65

11.75

2.3

9.79

10.31

g/l

1.26

226

1325

(3012544) pH of Venous blood

565

4199

1.40

11.61

4.3

4.0

7.38

0.11

254

2487

(3024354) Oxygen [Partial pressure] in Venous blood

477

3468

1.43

11.09

3.5

3.3

4.52

4.48

kpa

0.11

459

3368

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

689

5390

1.34

10.16

1.3

11.83

13.38

u/ml

0.21

238

2016

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

240

1545

1.59

10.06

1.1

1.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

615

4738

1.35

10.04

2.6

2.5

1.74

1.78

0.59

574

4206

(3002256) Pathology report gross observation

622

4801

1.35

10.03

1.4

—

(36660697) Celiac disease serology panel - Serum

360

2531

1.46

10.00

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

805

6462

1.31

9.85

3.4

3.3

0.81

mmol/l

0.02

759

6056

(3023520) Reticulocytes [#/volume] in Blood

491

3661

1.39

9.83

2.3

2.6

66.45

69.33

e9/l

1.06

323

2594

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

305

2082

1.50

9.82

3.8

2.9

1.23

1.20

0.20

305

2069

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

853

6904

1.30

9.81

3.5

3.3

0.82

ug/l

0.01

678

4786

(3021447) Carbon dioxide [Partial pressure] in Venous blood

549

4179

1.36

9.67

4.3

3.9

5.85

5.83

kpa

0.17

528

4070

(1002224) Polysomnography panel

206

1292

1.63

9.63

1.1

—

(3002032) Base excess in Venous blood by calculation

535

4062

1.37

9.57

4.3

3.9

1.78

1.82

mmol/l

0.08

476

3522

(3036489) Thrombin time

213

1352

1.61

9.49

1.6

2.1

21.51

21.21

0.25

200

1216

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1354

0.45

9.31

2.0

1.9

—

(3022145) Colonoscopy Study observation

505

3817

1.37

9.28

1.3

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

592

4591

1.34

9.20

4.8

4.4

232.35

249.55

u/l

2.98

568

4345

(40761536) Microorganisms panel - Urine sediment

169

2708

0.61

9.17

5.2

4.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1099

9254

1.26

9.07

4.7

23.10

22.25

0.94

551

4792

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1514

13207

1.23

9.07

4.3

4.1

2.23

0.24

estimate

0.43

226

3100

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

297

2053

1.48

9.00

3.7

2.9

0.61

0.62

0.13

297

2043

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1467

0.48

8.93

2.1

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

458

3438

1.37

8.78

2.7

2.6

65.98

66.12

g/l

0.16

435

3137

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

195

2985

0.64

8.68

5.2

3.8

1.22

1.23

mmol/l

0.34

169

2588

(3049717) Cytology report of Urine Cyto stain

227

1513

1.53

8.21

2.7

—

(3045424) Erythrocytes [Presence] in Urine

245

1660

1.51

8.20

2.1

2.2

0.00

0.52

estimate

0.53

133

509

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

184

1174

1.59

8.07

1.7

1.6

29.45

18.59

u/ml

0.60

240

(46235355) HIV 1 and 2 tests - Meaningful Use set

598

4739

1.31

7.92

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1807

16248

1.20

7.52

2.9

—

estimate

—

(3029937) Albumin [Presence] in Urine by Test strip

1153

9940

1.22

7.39

4.6

4.2

0.01

0.00

estimate

0.34

352

3463

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

135

817

1.67

7.33

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

135

817

1.67

7.33

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

937

1.62

7.21

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

150

941

1.62

7.09

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

163

2.53

7.08

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

1407

12422

1.20

6.97

3.7

3.5

7.15

7.24

mmol/l

0.33

1264

10419

(3037522) Nuclear Ab [Titer] in Serum

556

4439

1.29

6.93

1.4

1.3

555.81

492.00

titre

0.30

105

983

(42529406) Shigella sp [Presence] in Stool by Culture

150

947

1.61

6.92

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

125

754

1.68

6.90

1.3

1.5

35.52

26.21

e6/l

0.12

560

(3017446) Testosterone [Moles/volume] in Serum or Plasma

340

2540

1.37

6.71

2.4

2.2

12.04

12.60

nmol/l

0.62

300

2256

(3024928) Oxygen saturation in Venous blood

159

1029

1.57

6.62

2.6

3.1

61.62

60.11

0.33

153

998

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

125

765

1.65

6.55

1.3

1.5

522.33

1261.67

e6/l

1.00

100

603

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1037

8947

1.21

6.45

2.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

150

974

1.56

6.18

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

161

1069

1.53

6.01

3.2

3.5

2.29

1.96

index

0.29

567

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

385

2983

1.32

5.98

4.8

4.0

109.73

93.54

ng/l

1.41

343

2554

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

161

1073

1.52

5.91

2.5

3.71

3.65

g/l

0.23

156

1024

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

363

2796

1.33

5.88

3.6

2.7

59.28

63.74

ml/min/173m2

1.51

203

1213

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

780

6601

1.22

5.82

2.1

1.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

121

761

1.61

5.73

1.3

3.82

3.78

mmol/l

0.15

115

725

(4027681) Cerebrospinal fluid IgG ratio and IgG index

168

2.33

5.73

1.1

1.2

0.46

0.54

ratio

3.55

100

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

406

1.84

5.73

3.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

624

5167

1.25

5.70

6.8

6.1

1.04

1.05

mmol/l

0.63

587

4790

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

125

798

1.58

5.58

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

132

857

1.56

5.48

1.8

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1360

12172

1.18

5.44

4.3

4.2

7.80

10.98

mg/mmol

1.00

927

7639

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2260

21052

1.17

5.42

3.3

51.05

52.70

u/l

0.35

2133

19567

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1.91

5.29

1.1

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

259

1930

1.37

5.24

1.8

1.7

1.44

1.55

g/l

1.29

239

1669

(3005322) IgE [Units/volume] in Serum or Plasma

261

1949

1.36

5.21

1.4

1.3

174.89

223.18

u/ml

0.81

244

1796

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

236

2.05

5.15

1.3

1.2

79.68

88.80

u/l

0.28

203

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

110

696

1.60

5.13

1.3

1.2

31.40

47.39

u/ml

—

(3045414) Leukocytes [Presence] in Urine

419

3354

1.28

5.10

2.2

0.00

0.01

estimate

0.78

145

653

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

211

2.10

5.04

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

296

2271

1.33

4.95

9.5

9.9

16.24

15.82

2.06

290

2188

(3019230) Fractional oxyhemoglobin in Venous blood

128

847

1.53

4.92

2.3

2.7

61.64

60.68

0.18

128

842

(3008152) Bicarbonate [Moles/volume] in Arterial blood

309

2391

1.32

4.87

6.9

6.8

24.61

24.54

mmol/l

0.12

300

2275

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

208

2.08

4.83

1.8

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

208

2.08

4.83

1.8

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

230

2.01

4.74

1.2

15.87

21.03

u/l

0.64

194

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

247

1860

1.35

4.70

2.2

2.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

331

2605

1.29

4.62

3.4

2.9

10.26

10.66

g/l

0.74

315

2403

(3021879) Hepatitis B virus core Ab [Presence] in Serum

291

2260

1.31

4.49

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

125

845

1.49

4.39

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

412

3354

1.25

4.38

1.7

1.8

1.51

1.52

0.06

374

2904

(40759836) Histone Ab [Presence] in Serum by Immunoblot

280

1.87

4.36

1.0

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.10

4.35

1.1

1.0

5.42

9.69

mg/g

2.63

(3017143) Hepatitis C virus Ab [Presence] in Serum

412

3359

1.25

4.32

1.7

1.6

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

288

1.85

4.32

1.0

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

537

1.61

4.29

1.7

1.6

0.67

0.87

g/l

1.31

420

(3004716) Salmonella sp identified in Stool by Organism specific culture

194

1431

1.37

4.24

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

120

2.34

4.24

2.8

2.7

29.30

29.26

umol/l

0.01

(3005988) Vibrio sp identified in Specimen by Organism specific culture

433

0.37

4.22

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

433

0.37

4.22

1.3

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

172

2.10

4.22

1.1

1.23

1.20

u/l

0.07

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

139

968

1.45

4.21

1.6

0.24

g/l

0.09

131

920

(3025468) Yersinia sp identified in Specimen by Organism specific culture

431

0.37

4.18

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

155

1104

1.42

4.17

1.4

253.16

268.95

ug/g

0.39

667

(3036481) Cortisol [Moles/volume] in Serum or Plasma

393

3201

1.25

4.16

2.4

385.53

381.94

nmol/l

0.11

365

2964

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

195

1445

1.37

4.15

3.3

2.9

0.35

0.34

iu/ml

0.11

784

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.99

4.12

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

116

787

1.49

4.03

2.0

1.7

326.87

307.47

mu/l

0.25

109

727

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

146

1036

1.42

4.02

1.2

1.3

—

(3012516) Albumin [Mass/volume] in Urine

1311

11918

1.15

4.00

3.6

3.5

44.36

51.27

mg/l

0.53

882

7709

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1.84

4.00

1.0

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

141

996

1.43

3.98

1.6

1.24

1.19

g/l

0.99

133

945

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

173

1268

1.38

3.96

3.6

3.1

8.41

3.22

ratio

0.57

734

(3020779) Urea [Moles/volume] in Serum or Plasma

443

3683

1.23

3.90

7.9

7.2

10.46

10.72

mmol/l

0.28

423

3519

(3003694) ABO and Rh group [Type] in Blood

1040

9319

1.16

3.86

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1.80

3.79

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1.80

3.79

1.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

173

1279

1.37

3.77

1.5

1.6

0.24

0.32

mg/l

1.71

582

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

295

1.77

3.74

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

259

2033

1.29

3.74

2.0

1.9

1.29

1.37

g/l

0.24

243

1855

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

136

2.14

3.60

2.3

2.8

0.62

0.61

mmol/l

0.49

136

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

108

741

1.47

3.59

1.2

1.1

2.59

4.49

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

455

0.44

3.56

1.3

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

452

0.44

3.51

1.3

1.4

—

(3014891) Appearance of Pleural fluid

2.71

3.48

1.8

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

450

0.44

3.47

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

102

698

1.47

3.45

1.3

1.4

9.44

10.31

u/l

0.27

567

(3008898) HLA-B27 [Presence]

126

899

1.41

3.42

1.1

—

(3023410) Appearance of Cerebral spinal fluid

359

1.65

3.34

1.4

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

312

2543

1.25

3.33

1.6

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

2.47

3.29

3.2

2.2

5.58

0.17

e9/l

0.50

(3020874) Milk IgE Ab [Units/volume] in Serum

135

2.08

3.27

1.0

1.2

0.25

1.59

u/ml

1.30

(4146454) Self-monitoring of blood glucose

394

0.43

3.21

2.8

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

184

1410

1.32

3.21

3.8

3.3

62.49

49.37

mg/l

0.26

169

1202

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.34

3.19

1.1

1.3

0.31

0.60

iu/ml

—

(3016018) Differential panel - Cerebral spinal fluid

388

1.61

3.16

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

444

1.56

3.14

1.4

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.63

3.13

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

183

1407

1.31

3.13

1.9

39.40

39.34

u/l

0.01

170

1233

(3034860) Kappa light chains.free [Mass/volume] in Serum

183

1411

1.31

3.07

3.8

3.3

95.17

94.86

mg/l

0.00

167

1203

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

466

1.53

2.98

1.2

1.1

15.08

21.71

au/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

166

1269

1.32

2.97

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1305

0.70

2.96

4.1

4.8

25.34

24.86

mmol/l

0.67

1182

(21494890) Protein electrophoresis panel - 24 hour Urine

403

1.57

2.96

2.3

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

142

1064

1.35

2.92

1.4

29.75

30.40

iu/l

0.08

116

904

(3019309) Folate [Moles/volume] in Red Blood Cells

733

6529

1.15

2.90

1.7

1.8

1157.39

1153.96

nmol/l

0.03

583

4942

(3042111) Morphology [Interpretation] in Bone marrow Narrative

658

1.44

2.89

1.5

1.6

—

(40768443) Skin Pathology biopsy report

199

1567

1.28

2.87

1.3

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

104

745

1.41

2.82

1.3

1.2

3.73

3.78

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

179

1.85

2.81

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

166

1281

1.31

2.80

2.2

2.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

433

1.53

2.79

1.2

1.3

0.17

0.23

nmol/l

0.87

340

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

689

1.42

2.77

1.3

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

262

1.69

2.76

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

244

1981

1.25

2.74

2.8

3.5

4.45

4.46

pmol/l

0.04

218

1764

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

349

1.58

2.70

1.2

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

105

2.10

2.68

1.0

1.1

0.27

3.32

u/ml

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.15

2.64

1.0

1.5

—

(3024263) Appearance of Synovial fluid

198

1.77

2.63

2.1

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

266

1.66

2.62

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

377

1.55

2.58

3.2

3.7

12.65

11.97

index

0.28

212

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.01

2.56

1.3

1.2

0.94

1.27

iu/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

443

1.50

2.54

2.1

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

101

2.08

2.52

2.3

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

428

1.50

2.51

1.1

0.31

1.43

u/ml

1.97

195

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

771

0.64

2.51

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

340

1.57

2.51

1.1

—

5.45

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

232

1.69

2.48

1.3

3.63

2.94

u/ml

0.10

138

(3025018) Bordetella pertussis Ab [Titer] in Serum

195

1.75

2.46

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

392

0.51

2.45

1.5

1.2

—

(3042733) HLA Ab [Presence] in Serum

2.14

2.44

7.5

4.7

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

174

1.79

2.41

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

189

0.37

2.40

3.3

3.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.26

2.37

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.12

2.36

3.4

4.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.04

2.35

1.5

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

110

824

1.34

2.33

2.1

2.7

29.32

35.02

umol/l

1.88

740

(3009466) Valproate [Moles/volume] in Serum or Plasma

477

1.45

2.33

5.1

5.2

354.07

349.70

umol/l

0.08

420

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

260

1.62

2.32

1.1

32.00

146.98

titre

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

317

0.47

2.31

1.3

2.0

1.88

1.61

u/field

—

170

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

139

1080

1.30

2.29

1.8

1.7

—

(4024509) Urine culture

205

1672

1.24

2.26

2.3

2.0

—

(3025159) Blasts/Leukocytes in Blood

362

3119

1.18

2.25

5.3

4.5

0.10

0.21

0.48

839

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

490

1.44

2.22

1.2

1.3

0.55

4.29

nmol/l

0.52

470

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.56

2.21

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

304

1.55

2.18

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

515

0.60

2.18

2.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

151

1196

1.27

2.16

2.2

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

121

931

1.31

2.16

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

181

0.39

2.15

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

181

0.39

2.15

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.62

2.14

1.7

1.1

102.45

100.95

0.07

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

395

1.48

2.13

1.2

67.10

65.71

u/l

0.07

347

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

562

1.40

2.13

1.8

1.5

155.66

155.95

au/ml

0.01

171

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.05

2.11

1.0

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

463

1.43

2.09

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

463

1.43

2.09

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

463

1.43

2.09

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

463

1.43

2.09

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

191

1.68

2.06

1.1

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

469

4152

1.15

2.05

1.7

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

350

1.49

2.04

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

443

1.43

1.99

1.1

5.56

4.48

u/ml

0.15

243

(3014599) Egg white IgE Ab [Units/volume] in Serum

126

1.83

1.98

1.0

1.2

0.53

2.62

u/ml

0.93

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

186

1.67

1.97

6.5

7.1

2.37

122.18

ug/l

0.68

114

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

261

2215

1.19

1.96

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

428

1.43

1.95

1.9

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

412

1.44

1.94

1.9

2.0

—

2.75

—

(3007566) Smooth muscle Ab [Titer] in Serum

118

921

1.29

1.93

1.3

1.2

188.33

107.76

titre

0.35

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

160

1296

1.24

1.92

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

701

0.68

1.92

1.4

1.5

226.26

194.14

pmol/l

0.15

686

(3037756) Immunofixation for Serum or Plasma

110

852

1.30

1.91

1.8

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.06

1.90

1.3

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

315

1.50

1.90

1.2

1.3

15.81

12.13

u/l

0.58

290

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.96

1.89

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

155

1254

1.25

1.89

1.3

1.2

0.26

1.39

u/ml

1.83

(4062490) Immunoglobulin typing, IgG

317

1.49

1.85

1.6

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

595

1.35

1.84

1.7

1.9

4.95

4.87

mmol/24h

0.06

520

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.53

1.83

1.0

3.9

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.53

1.83

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

409

1.42

1.83

1.1

1.3

—

nmol/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.17

1.82

1.0

1.1

292.88

237.33

nmol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

102

788

1.30

1.82

1.8

1.6

—

(3025130) Human papilloma virus identified in Specimen

418

1.42

1.81

1.5

1.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

235

0.47

1.80

2.4

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

719

1.31

1.80

4.4

5.1

2648.77

2666.18

iu/ml

0.00

102

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.00

1.79

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

0.50

1.77

2.2

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

109

1.84

1.77

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

256

1.53

1.75

1.4

—

(3042517) Benzodiazepines panel - Urine

3.34

1.74

2.0

2.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

636

1.33

1.74

1.9

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

132

1.75

1.73

1.1

1.3

147.11

158.67

mmol/24h

0.36

132

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

119

945

1.27

1.73

1.4

1.2

40.41

37.88

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.92

1.72

2.4

2.6

—

(3035285) Chloride [Moles/volume] in Venous blood

458

0.63

1.72

3.2

2.4

106.59

105.29

mmol/l

0.80

452

(3041354) Potassium [Moles/volume] in Venous blood

458

0.63

1.72

3.2

2.4

4.12

4.09

mmol/l

0.15

452

(3021440) Promyelocytes/Leukocytes in Blood

353

3108

1.15

1.70

5.3

4.4

0.10

0.12

0.18

904

(3003181) Sodium [Moles/volume] in Urine

744

1.30

1.69

2.1

1.4

59.52

60.71

mmol/l

0.10

598

(3028192) IgG subclass 2 [Mass/volume] in Serum

324

1.46

1.69

1.6

1.3

2.87

3.02

g/l

0.26

234

(3024139) IgG subclass 3 [Mass/volume] in Serum

324

1.46

1.69

1.6

1.3

0.39

0.40

g/l

0.14

236

(3027135) IgG subclass 1 [Mass/volume] in Serum

324

1.46

1.69

1.6

1.3

6.19

6.98

g/l

1.56

236

(3014148) Varicella zoster virus Ab [Titer] in Serum

349

1.44

1.68

1.1

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

332

0.57

1.68

1.2

1.1

—

3.19

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

751

0.72

1.68

4.0

3.6

27.05

28.17

mg/l

0.09

540

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

219

1.56

1.67

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

280

0.53

1.67

1.3

1.1

—

75.40

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

1.68

1.66

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

367

3247

1.14

1.66

5.3

4.3

0.81

0.93

0.42

104

1041

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

616

1.32

1.64

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

583

0.68

1.63

1.7

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

177

1479

1.21

1.62

3.9

3.3

38.75

3781.96

u/ml

1.28

154

1264

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

158

1.65

1.62

1.2

1.4

—

73.38

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

188

0.48

1.61

2.0

2.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

314

0.57

1.60

2.2

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

479

4322

1.12

1.59

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

115

921

1.26

1.58

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.70

1.58

1.1

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

638

1.31

1.57

1.8

1.4

—

20.44

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

123

994

1.24

1.57

2.1

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

447

0.65

1.56

3.2

2.5

1.21

1.20

mmol/l

0.74

441

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

231

1.52

1.56

1.8

—

(3012501) Base excess in Blood by calculation

740

0.73

1.56

8.0

4.6

3.01

2.76

mmol/l

0.25

528

(3023511) Choriogonadotropin [Units/volume] in Urine

322

1.43

1.55

1.5

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

432

0.65

1.52

4.0

1.8

89.56

89.53

0.01

423

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.34

1.52

1.6

1.3

881.72

500.18

nmol/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

309

0.58

1.52

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.60

1.51

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

461

4166

1.12

1.50

3.8

4.1

5.79

26.86

ug/l

4.83

368

3444

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.86

1.50

1.3

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

111

893

1.25

1.48

1.4

1.2

5.48

3.24

u/ml

0.55

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

645

1.29

1.47

2.2

2.0

7206.90

4779.25

u/l

0.25

266

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

428

1.36

1.46

1.3

538.15

326.85

u/l

0.38

407

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

228

0.52

1.44

2.3

1.4

—

(3022621) pH of Urine by Test strip

245

2808

0.86

1.44

2.7

2.8

6.03

6.05

0.12

168

1988

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

336

1.40

1.43

1.6

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

303

0.59

1.43

1.4

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

204

1.52

1.42

3.1

2.0

0.59

0.62

e9/l

0.13

190

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

196

1.53

1.42

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.82

1.41

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

136

0.44

1.40

1.8

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

136

0.44

1.40

1.8

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

136

0.44

1.40

1.8

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

1.67

1.39

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

362

0.63

1.39

2.8

4.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

111

1.72

1.39

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.08

1.38

11.2

13.7

4.60

5.67

mmol/l

1.17

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.20

1.37

1.1

—

(3022670) pH of Venous cord blood

2.94

1.36

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

306

1.41

1.36

1.7

1.5

11.63

24.04

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

191

1.52

1.34

2.9

2.4

35.12

39.79

0.65

100

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

109

888

1.23

1.33

1.6

1.9

2.99

4.18

iu/l

1.00

341

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

1.32

0.0

2.3

—

0.68

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

532

1.30

1.32

1.2

1.1

0.74

2.03

u/ml

2.28

302

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

109

889

1.23

1.32

2.1

1.9

13.06

11.82

mg/l

1.14

100

833

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

283

1.42

1.31

6.6

5.5

145.64

71.99

u/ml

0.24

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

129

1.63

1.29

1.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

294

0.61

1.29

1.4

1.10

1.27

1.48

213

(40768800) Prostate Pathology biopsy report

100

812

1.24

1.27

1.1

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

177

1518

1.17

1.27

1.6

1.7

25.70

20.82

iu/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

210

1.48

1.27

1.0

1.1

20.99

9.44

iu/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

208

1808

1.16

1.26

4.7

3.5

25.27

25.22

mmol/l

0.08

198

1747

(3022313) Gas panel - Capillary blood

143

1690

0.84

1.26

3.7

4.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

231

2025

1.15

1.25

2.0

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

261

1.42

1.24

2.6

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

389

1.34

1.24

1.3

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.04

1.22

1.1

0.50

8.10

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.16

1.21

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

263

1.41

1.20

1.3

2.15

2.21

mmol/l

0.07

247

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

213

1.46

1.20

1.1

7.44

10.47

nmol/l

—

(4198724) Urine methamphetamine measurement

1.70

1.17

2.2

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

108

895

1.21

1.16

1.4

1.3

11.96

5.74

u/ml

0.43

116

(3023430) Cat dander IgE Ab [Units/volume] in Serum

325

1.36

1.15

1.1

6.44

3.75

u/ml

0.29

149

(3005532) Lymphocytes/Leukocytes in Pleural fluid

174

1.50

1.15

1.4

1.6

71.84

68.03

0.24

148

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

368

0.68

1.15

1.5

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

415

0.70

1.15

1.6

2.2

6.83

23.90

mg/l

—

149

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

234

2641

0.88

1.15

1.9

2.0

3.47

3.44

ratio

0.16

180

2089

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

509

1.28

1.14

1.1

1.2

3.75

3.62

u/ml

0.02

180

(3035933) Granulocytes/Leukocytes in Blood

734

0.77

1.14

3.3

3.5

59.10

58.22

0.25

734

(4195642) Thrombophilia screening test

457

1.30

1.13

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

246

0.61

1.12

1.3

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

529

1.27

1.11

6.0

6.3

11.43

12.19

mg/l

0.84

482

(3041096) Erythrocytes [Presence] in Urine by Automated

974

9241

1.07

1.10

3.7

3.6

0.00

0.31

estimate

1.43

226

2974

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.26

1.10

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

468

1.29

1.10

1.3

384.44

308.93

pmol/l

0.58

396

(3025941) Bacteria identified in Stool by Culture

194

1700

1.15

1.09

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

347

3813

0.90

1.08

3.8

3.7

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.73

1.08

1.1

1.4

23.13

22.14

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.95

1.08

1.3

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.95

1.08

1.8

1.6

—

(3017732) Neutrophils [#/volume] in Blood

386

4218

0.91

1.08

3.8

3.3

4.69

4.71

e9/l

0.01

342

3622

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

243

0.62

1.08

1.3

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

244

1.40

1.07

3.0

2.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

409

1.30

1.06

1.2

1.1

1.21

1.52

u/ml

0.16

223

(3020650) Glucose [Presence] in Urine

122

0.49

1.05

1.2

1.9

0.00

estimate

—

122

(21494434) Karyotype in Bone marrow

340

1.33

1.04

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

187

1.45

1.03

1.0

1.2

140.04

138.53

nmol/l

0.05

187

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

500

1.26

1.02

1.2

2.63

4.68

u/ml

1.01

230

(3000475) Leukocytes [#/volume] in Synovial fluid

112

945

1.19

1.02

1.6

14073.77

12393.74

e6/l

0.17

638

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

396

1.29

0.99

1.1

1.61

3.71

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

133

0.53

0.98

1.0

1.1

—

5.76

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.18

0.98

1.6

1.3

8.84

7.36

u/ml

—

(3024932) HLA-DR beta [Type]

1.67

0.97

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

116

989

1.18

0.96

1.6

1.7

3.69

4.64

mg/l

0.32

740

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

157

1.47

0.96

1.4

1.7

1.29

7.60

nmol/l

1.46

134

(4268621) Lupus anticoagulant assay

355

1.30

0.94

2.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

398

0.73

0.94

1.4

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

0.93

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

104

881

1.19

0.93

3.5

3.3

0.76

0.84

nmol/l

1.38

704

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

777

0.81

0.92

1.0

1.1

0.60

0.61

ratio

0.06

118

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

150

1.47

0.92

1.8

2.2

132.29

121.18

umol/l

0.06

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

142

1.48

0.92

1.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

221

1982

1.12

0.91

1.7

—

(3012441) Differential panel - Pleural fluid

491

1.25

0.91

1.5

—

(3024471) HLA-A [Type]

1.63

0.90

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

840

0.82

0.90

1.1

1.2

1.52

1.54

g/l

0.37

840

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

120

1033

1.17

0.89

1.4

1.5

0.03

10.48

iu/ml

0.87

194

(44806420) Estimation of glomerular filtration rate

325

0.71

0.89

2.0

2.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

359

0.72

0.89

1.5

1.29

1.15

ratio

0.21

230

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

359

0.72

0.89

1.5

1.16

1.24

ratio

0.14

230

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

359

0.72

0.89

1.5

0.87

0.96

ratio

1.24

230

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

127

1.50

0.88

1.3

1.4

—

1469149.88

iu/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

101

859

1.18

0.88

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.00

0.87

1.0

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

442

1.25

0.84

1.3

1.4

6.33

6.43

mmol/l

0.12

420

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

104

1.54

0.84

2.2

1.9

16.72

67.90

u/l

1.40

(4212803) Bone marrow aspirate examination

1.78

0.84

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

525

1.22

0.82

2.4

2.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.88

0.81

1.5

1.1

69.33

102.00

titre

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

105

1.53

0.81

1.1

1.5

75.00

142.58

nmol/24h

0.56

105

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

686

0.81

0.80

1.7

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

573

1.21

0.79

1.4

1.3

262.23

273.71

u/ml

0.16

340

(3008295) Osmolality of Serum or Plasma

410

1.25

0.79

1.5

1.4

279.83

277.74

mosm/kgh2o

0.23

303

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

350

0.74

0.78

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

358

1.26

0.77

1.1

1.45

3.90

u/ml

1.40

188

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.76

0.0

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.70

0.75

1.4

1.2

—

(3006462) Nitrate [Presence] in Urine

161

0.62

0.75

6.0

3.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

347

0.75

0.74

2.7

3.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

642

1.19

0.74

1.4

1.5

33.01

31.76

g/l

0.35

577

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

113

986

1.15

0.74

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

1069

11093

0.95

0.74

3.1

3.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.84

0.73

1.9

3.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.84

0.73

1.3

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

109

951

1.15

0.72

1.9

2.2

132.18

127.44

g/l

1.15

725

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

666

0.82

0.72

1.7

1.6

836.31

1003.78

mu/l

0.71

558

(3023420) DNA double strand Ab [Units/volume] in Serum

152

1357

1.12

0.72

1.6

1.7

4.70

6.75

iu/ml

0.73

310

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

185

1.35

0.71

1.0

1.1

34.90

17.05

u/ml

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.75

0.71

1.6

2.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.58

0.71

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

554

1.19

0.70

1.2

1.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

331

3078

1.08

0.70

4.6

4.3

0.47

0.67

1.06

972

(3035637) Corticotropin [Mass/volume] in Plasma

436

1.22

0.69

1.6

32.23

29.22

ng/l

0.11

436

(40768446) Kidney Pathology biopsy report

135

1.41

0.69

2.3

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.56

0.68

1.1

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

117

0.60

0.67

2.6

2.1

1.58

1.77

ratio

—

109

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.54

0.67

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

136

1.40

0.66

1.3

1.1

48.63

411.03

ng/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

347

3241

1.08

0.66

2.7

3.0

146.06

234.50

ng/l

6.75

324

2955

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

820

0.85

0.66

2.7

3.5

201.83

744.67

u/ml

0.82

753

(21494755) Public health laboratory ask at order entry panel

181

1989

0.91

0.64

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

477

1.20

0.64

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

1.32

0.64

1.3

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

127

0.63

0.64

1.3

1.4

3.54

3.28

mmol/l

—

113

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

359

1.23

0.63

1.5

0.28

0.31

nmol/l

0.23

266

(44813793) Dust mix specific IgE antibody measurement

190

1.32

0.62

1.1

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

0.58

0.62

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.59

0.61

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

554

1.18

0.61

1.5

2058.76

3480.79

e6/l

0.40

384

(37208534) Antinuclear antibody arbitrary concentration in serum

113

1.42

0.61

1.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

298

1.24

0.60

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

705

0.85

0.60

1.6

1.3

—

(4211845) Urine protein measurement

175

0.68

0.60

5.3

3.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

174

1906

0.91

0.59

1.7

1.8

3.36

3.46

mmol/l

0.33

119

1349

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.54

0.59

1.3

15.16

7.23

mg/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.59

0.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.53

0.59

3.5

2.6

322.91

91.53

ug/l

0.31

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

166

1.33

0.58

1.1

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

185

0.70

0.58

1.7

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

185

0.70

0.58

1.7

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

185

0.70

0.58

1.7

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

185

0.70

0.58

1.7

1.5

—

(3045716) Anion gap in Serum or Plasma by calculation

430

0.81

0.57

2.1

2.9

11.24

10.41

mmol/l

0.86

423

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.67

0.56

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.57

0.56

7.4

8.3

5.98

5.93

kpa

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

185

1.30

0.56

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.62

0.55

1.5

1.1

—

(3010503) CD19 cells [#/volume] in Blood

206

0.73

0.55

2.5

2.2

117.07

133.46

e6/l

0.13

195

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

312

1.22

0.54

1.1

1.0

0.45

0.33

u/ml

0.13

120

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

469

1.18

0.53

1.1

1.2

123.82

115.59

1.13

422

(3035320) C reactive protein [Mass/volume] in Body fluid

282

0.78

0.52

3.5

2.8

15.50

31.52

mg/l

2.18

207

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

809

1.13

0.51

1.5

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

607

0.85

0.51

2.8

4.1

15.57

33.80

u/ml

4.82

591

(3028707) Methadone [Presence] in Urine by Screen method

343

1.20

0.50

2.6

2.4

—

(3044927) Protein electrophoresis panel - Urine

389

0.82

0.49

1.2

—

(3028433) Virus identified in Specimen by Culture

110

0.64

0.48

1.0

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

493

1.16

0.48

2.4

2.1

0.93

1.30

g/24h

0.56

290

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

252

2363

1.07

0.48

1.5

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

655

0.87

0.47

1.4

1.3

170.00

440.00

titre

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

104

940

1.11

0.46

1.2

1.4

—

(3016879) Cocaine [Presence] in Urine

704

1.12

0.45

1.9

2.0

—

(3045788) Cell count panel - Pleural fluid

460

1.15

0.44

1.5

1.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

148

1.29

0.43

11.5

13.3

0.63

0.62

mmol/l

0.06

137

(4281824) Cell count and differential, peritoneal fluid

387

1.16

0.42

1.0

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

230

1.22

0.42

2.2

1.9

175.84

122.62

ng/l

0.37

230

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.64

0.42

27.0

7.6

75.67

74.59

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

481

1.15

0.42

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

500

1.14

0.42

1.5

1.4

241096.20

57182.30

e6/l

1.02

282

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

743

0.89

0.42

1.3

222.01

209.33

miu/ml

0.09

314

(3034274) Bile acid [Moles/volume] in Serum --fasting

249

1.21

0.41

2.2

2.1

4.57

7.42

umol/l

1.34

180

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

3.53

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.41

0.0

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.12

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.41

0.0

1.3

—

1.22

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

105

1.33

0.41

1.2

2.1

169.36

175.60

0.12

100

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

493

1.14

0.39

1.6

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.43

0.39

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

161

1726

0.93

0.39

3.8

5.1

1.81

1.59

1.19

156

1621

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

857

1.10

0.37

2.7

2.3

129.54

95.73

ug/min

0.27

510

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

467

1.14

0.37

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

515

0.87

0.37

1.7

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.32

0.37

1.6

1.9

—

(3000012) Reticulocyte production index

589

0.88

0.37

2.2

2.1

0.83

0.87

0.24

413

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

280

1.18

0.37

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

562

1.12

0.37

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.31

0.37

1.1

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

1.29

0.37

6.4

2.6

5.22

4.85

kpa

0.40

116

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

1.29

0.37

6.4

2.6

10.07

9.95

kpa

0.07

116

(3050129) First trimester maternal screen panel - Serum or Plasma

429

0.86

0.37

1.6

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

337

1.16

0.36

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

244

1.19

0.36

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.33

0.35

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.64

0.35

7.4

8.6

7.32

5.36

kpa

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

147

1574

0.93

0.35

4.4

5.3

0.88

0.85

0.35

142

1478

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

153

1.24

0.35

1.1

1690.08

1619.02

miu/ml

0.12

153

(3047189) Immunofixation for 24 hour Urine

199

1.21

0.35

1.8

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

134

0.75

0.34

1.3

—

(40768806) Pleura Pathology biopsy report

480

1.13

0.34

1.6

1.5

—

(3000285) Sodium [Moles/volume] in Blood

1.37

0.34

1.5

1.1

138.50

138.53

mmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

237

1.18

0.33

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

701

1.10

0.33

1.5

1.3

—

(3027944) Amphetamines [Presence] in Urine

749

1.10

0.33

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.69

0.33

1.3

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

331

1.15

0.33

1.5

1.4

29.59

27.32

u/l

0.16

274

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.33

0.32

1.0

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

769

7508

1.03

0.30

1.8

1.7

79511145.52

29046144.18

pmol/l

0.91

654

6235

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

120

1.25

0.30

1.3

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.27

0.30

1.0

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

166

1.21

0.29

1.1

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.25

0.29

1.3

5.0

29.71

40.19

umol/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

250

1.16

0.29

1.7

1.9

8.62

8.32

mmol/l

0.15

250

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.29

0.28

1.1

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

118

0.76

0.27

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

118

0.76

0.27

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

118

0.76

0.27

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

118

0.76

0.27

1.0

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

131

1.22

0.27

1.3

1.5

13.88

19.18

0.40

122

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

224

1.16

0.27

1.8

1.5

3.60

7.25

u/l

1.60

183

(3000764) Benzodiazepines [Presence] in Urine

760

1.08

0.26

1.9

2.0

—

(3009343) pH of Capillary blood

234

2439

0.96

0.26

3.9

4.3

7.42

0.12

205

2018

(3027008) Opiates [Presence] in Urine

761

1.08

0.25

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

263

1.14

0.25

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

160

1.19

0.25

1.3

185.92

220.38

pmol/l

0.25

160

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

273

1.14

0.25

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

180

0.83

0.24

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

600

1.08

0.23

2.0

1.9

—

(3004451) EKG impression Narrative

233

0.86

0.23

1.4

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.32

0.23

3.2

6.0

76.00

56.31

ug/min

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.28

0.23

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.25

0.22

1.0

1.5

—

(3028300) Cannabinoids [Presence] in Urine

767

1.07

0.22

1.9

2.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.22

0.22

1.4

1.3

—

619.04

—

(3044007) Cell count panel - Peritoneal fluid

124

0.81

0.21

1.3

1.8

—

(3034426) Prothrombin time (PT)

107

1.22

0.21

1.1

1.3

27.08

28.40

0.64

107

(3006576) Bicarbonate [Moles/volume] in Blood

107

1.22

0.21

12.3

7.7

24.56

24.94

mmol/l

0.16

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.19

0.21

1.8

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

3.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

242.39

—

(4038314) Semen analysis, post vasectomy

0.00

0.21

0.0

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.04

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

0.78

0.21

1.3

1.1

—

(3006598) pH of Arterial cord blood

1.16

0.21

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

1.16

0.21

1.0

—

-3.08

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.12

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.05

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

271

0.88

0.20

2.1

1.7

—

(3037121) Protein [Mass/volume] in Urine

117

1229

0.95

0.19

3.5

319.41

422.40

mg/l

0.58

548

(3016228) CD19 cells/cells in Blood

133

0.83

0.19

2.1

2.0

9.73

8.09

0.14

125

(3003329) Lymphocytes/Leukocytes in Synovial fluid

308

1.10

0.19

1.4

1.5

34.70

28.52

0.41

187

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

109

1.19

0.18

1.0

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.21

0.18

1.1

81.39

43.18

u/ml

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

338

1.10

0.18

1.2

1.4

184812.13

109067.75

e6/l

0.17

224

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

204

1.13

0.18

1.2

1.8

3.22

4.58

ug/l

0.30

166

(3024869) Neuronal Ab [Presence] in Serum

1.13

0.17

1.3

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

131

0.84

0.17

2.1

34.18

28.85

0.63

131

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

336

3280

1.03

0.17

2.1

2.3

7.12

7.40

ug/l

0.07

301

2853

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

374

3661

1.02

0.15

2.4

2.2

0.22

0.20

g/l

2.82

358

3407

(3023419) Bacteria identified in Sputum by Culture

506

1.07

0.15

2.5

2.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.78

0.15

1.8

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

0.76

0.15

1.7

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.76

0.15

1.3

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

293

1.09

0.15

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.13

0.15

1.9

1.6

8.11

8.75

ug/l

—

(40768793) Breast Pathology biopsy report

810

0.95

0.15

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

265

0.91

0.15

1.2

1.3

0.83

1.05

promille

0.39

212

(3035880) pH of Pleural fluid

244

0.90

0.14

1.5

1.4

7.37

7.41

0.27

165

(3017704) Immunofixation for Urine

208

1.11

0.14

2.4

1.6

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

392

1.07

0.14

1.4

1.6

62.38

60.94

0.08

243

(3040151) Glucose [Moles/volume] in Capillary blood

441

1.07

0.13

6.6

5.8

7.88

7.49

mmol/l

0.23

373

(40767503) Oxygen content in Capillary blood by calculation

776

0.95

0.13

3.4

2.6

16.33

16.12

0.25

758

(3000330) Specific gravity of Urine by Test strip

187

1922

0.97

0.13

3.5

3.4

1.02

ratio

1.23

161

1731

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

673

0.95

0.13

1.4

1.8

0.84

0.87

nmol/l

0.15

566

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

519

0.94

0.12

1.1

21.92

92.51

iu/ml

—

108

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

168

0.89

0.11

28.2

18.0

1483.80

1435.56

nmol/l

0.09

163

(40768441) Liver Pathology biopsy report

259

1.08

0.11

1.1

1.4

—

(40765096) Chromosome analysis panel by Banding

115

0.87

0.10

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

107

1103

0.97

0.10

5.3

6.1

1.37

1.29

mmol/l

0.27

973

(3005011) Chlamydia sp Ab [Titer] in Serum

1.04

0.09

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

115

1182

0.97

0.09

1.5

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.11

0.09

1.2

1.3

—

80.78

—

(3028717) Thiamine [Mass/volume] in Blood

1.11

0.09

1.0

1.3

70.00

64.20

ug/l

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.09

0.08

1.3

1.8

—

82.42

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.09

0.08

1.0

32.39

41.56

iu/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

419

0.95

0.08

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

317

0.95

0.07

1.7

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

264

1.06

0.07

1.0

283.79

292.83

mg/l

0.31

241

(4015189) Microbial culture of sputum

1.07

0.07

1.4

2.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

211

2144

0.98

0.07

3.9

4.2

2.47

1.98

mmol/l

1.06

140

1590

(40757373) Influenza virus identified in Isolate

0.87

0.07

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

314

1.05

0.07

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

314

1.05

0.07

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

314

1.05

0.07

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.02

0.07

2.9

1.2

14.71

16.94

umol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.84

0.06

1.4

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

165

1623

1.02

0.06

2.1

1.9

1.62

2.57

ug/l

0.67

153

1422

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

901

0.98

0.06

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

162

0.93

0.06

22.5

13.5

940.80

813.24

nmol/l

0.39

157

(1761482) Bacteria [#/volume] in Urine by Culture

890

1.02

0.05

4.7

4.3

—

(3017569) Oxygen content in Arterial blood

253

0.95

0.05

2.7

2.1

16.69

15.96

0.51

253

(3013166) Neutrophils/Leukocytes in Synovial fluid

110

1.09

0.05

1.3

51.11

62.57

0.52

(3045683) HLA typing for celiac disease panel - Blood or Tissue

171

0.94

0.05

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

120

1.08

0.04

1.0

1.2

10.92

10.78

mm/h

0.02

120

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

968

0.98

0.04

1.6

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

383

0.97

0.04

1.1

1.45

2.38

eliau/ml

0.94

148

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

745

1.02

0.04

1.1

0.84

6.93

eliau/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

362

0.97

0.04

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

729

7264

1.00

0.03

5.0

4.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

449

1.02

0.03

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

209

0.96

0.03

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

204

2024

1.01

0.03

1.2

144.63

140.94

u/ml

0.04

712

(3002523) Influenza virus A Ag [Presence] in Specimen

450

1.02

0.02

1.1

—

(1616796) Gas panel - Central venous blood

851

0.99

0.02

4.9

4.0

—

(4035726) Immunohistochemistry procedure

332

3335

1.00

0.02

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.08

0.02

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.08

0.02

1.3

1.1

—

(40768795) Lymph node Pathology biopsy report

358

0.98

0.01

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

143

1.05

0.01

1.2

2.0

793.20

737.29

e6/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

167

0.96

0.01

3.4

2.6

1.38

1.16

0.24

167

(1617658) Protocol used for examination of sentinel lymph nodes

257

0.97

0.01

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

263

1.03

0.01

1.1

1.0

642.52

694.56

ng/l

0.22

172

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

263

1.03

0.01

1.1

1.0

313.09

307.01

ng/l

0.04

179

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

503

1.01

0.01

1.6

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

104

1.06

0.01

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

0.95

0.00

1.1

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

194

1.03

0.00

3.7

4.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

206

0.97

0.00

1.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

108

1.02

0.00

1.5

1.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

205

0.98

0.00

1.0

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

265

1.02

0.00

1.1

1.0

40.51

41.18

ng/l

0.03

177

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

131

0.99

0.00

1.1

1.3

2.14

355.01

ug/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

159

1.01

0.00

2.6

1.7

39.04

39.74

g/l

0.20

159

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

231

1.00

0.00

1.8

1.6

62.93

54.46

ug/l

0.37

231

(3006442) Creatine [Moles/volume] in Serum or Plasma

229

1.00

0.00

1.5

1.6

150.48

85.16

umol/l

0.62

229

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

991

1.00

0.00

1.6

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

286

1.01

0.00

1.0

1.2

93.76

104.66

pmol/l

0.78

286

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

126

1.03

0.00

1.2

1.8

2842.43

22089.68

e6/l

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

251

2513

1.00

0.00

3.9

4.3

5.11

5.15

kpa

0.32

238

2397

(3021788) Differential panel - Synovial fluid

693

1.00

0.00

1.6

1.5

—

1.00

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

117

1.03

0.00

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.97

0.00

1.2

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3033099) Centromere Ab [Titer] in Serum

0.95

-0.00

1.3

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

343.83

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.98

-0.00

1.6

0.58

0.50

e9/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.98

-0.00

1.4

1.17

mmol/l

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.90

-0.00

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.99

-0.00

1.5

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

13.10

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.6

—

1.96

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.98

-0.00

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.94

-0.00

2.4

2.2

1.44

2.04

ratio

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_HL_NAS	1.051 [0.94, 1.18]	0.386
Birth year	0.994 [0.99, 1.0]	0.125

During the follow-up period (1.1.1998 — 31.12.2019), 3190 out of 11949 females with H8_HL_NAS died.

Males

Parameter	HR [95% CI]	p-value
H8_HL_NAS	1.146 [1.0, 1.31]	0.048
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2866 out of 10220 males with H8_HL_NAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_NAS.

N-year risk	Females	Males
1	0.097%	0.217%
5	0.537%	1.333%
10	1.297%	3.267%
15	2.614%	6.252%
20	4.635%	10.136%

Relationships between endpoints

↥

Index endpoint: H8_HL_NAS – Other specified/unspecified hearing loss

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specified/unspecified hearing loss

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints